{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:09:54Z","timestamp":1788822594712,"version":"build-2803163510"},"reference-count":486,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173319"],"award-info":[{"award-number":["82173319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373054"],"award-info":[{"award-number":["82373054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02811-4","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:02:25Z","timestamp":1788822145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["B cells in cancer: functions, mechanisms and therapeutic advances"],"prefix":"10.1038","volume":"11","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0558-5210","authenticated-orcid":false,"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2706-5117","authenticated-orcid":false,"given":"Zheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8636-0493","authenticated-orcid":false,"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3184-9907","authenticated-orcid":false,"given":"Wanguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2811_CR1","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano, L., Jord\u0101o, M. J. C. & Joyce, J. A. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 11, 933\u2013959 (2021).","journal-title":"Cancer Discov."},{"key":"2811_CR2","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw, D. C. & Shevde, L. A. The tumor microenvironment innately modulates cancer progression. Cancer Res 79, 4557\u20134566 (2019).","journal-title":"Cancer Res"},{"key":"2811_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","volume":"11","author":"Q Jia","year":"2022","unstructured":"Jia, Q., Wang, A., Yuan, Y., Zhu, B. & Long, H. Heterogeneity of the tumor immune microenvironment and its clinical relevance. Exp. Hematol. Oncol. 11, 24 (2022).","journal-title":"Exp. Hematol. Oncol."},{"key":"2811_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj4857","volume":"384","author":"J Ma","year":"2024","unstructured":"Ma, J. et al. A blueprint for tumor-infiltrating B cells across human cancers. Science 384, eadj4857 (2024).","journal-title":"Science"},{"key":"2811_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pancancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"2811_CR6","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1097\/HEP.0000000000001244","volume":"82","author":"K Cheng","year":"2025","unstructured":"Cheng, K. et al. Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma. Hepatology 82, 1414\u20131431 (2025).","journal-title":"Hepatology"},{"key":"2811_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41588-018-0339-x","volume":"51","author":"X Hu","year":"2019","unstructured":"Hu, X. et al. Landscape of B-cell immunity and related immune evasion in human cancers. Nat. Genet. 51, 560\u2013567 (2019).","journal-title":"Nat. Genet."},{"key":"2811_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","volume":"22","author":"CM Laumont","year":"2022","unstructured":"Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P. & Nelson, B. H. Tumor-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat. Rev. Cancer 22, 414\u2013430 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"2811_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7150\/thno.105423","volume":"15","author":"X Wu","year":"2025","unstructured":"Wu, X. et al. B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications. Theranostics 15, 605\u2013631 (2025).","journal-title":"Theranostics"},{"key":"2811_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Signal Transduct. Target Ther. 9, 225 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2811_CR11","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher, T. N. & Thommen, D. S. Tertiary lymphoid structures in cancer. Science 375, eabf9419 (2022).","journal-title":"Science"},{"key":"2811_CR12","doi-asserted-by":"publisher","first-page":"e012860","DOI":"10.1136\/jitc-2025-012860","volume":"13","author":"O Melaiu","year":"2025","unstructured":"Melaiu, O. et al. Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma. J. Immunother. Cancer 13, e012860 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00460-1","volume":"11","author":"E Zhang","year":"2023","unstructured":"Zhang, E. et al. Roles and mechanisms of tumor-infiltrating B cells in human cancer: a new force in immunotherapy. Biomark. Res. 11, 28 (2023).","journal-title":"Biomark. Res."},{"key":"2811_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40425-016-0145-x","volume":"4","author":"M Schwartz","year":"2016","unstructured":"Schwartz, M., Zhang, Y. & Rosenblatt, J. D. B-cell regulation of the anti-tumor response and role in carcinogenesis. J. Immunother. Cancer 4, 40 (2016).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR15","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui, C. et al. Neoantigen-driven B-cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell 184, 6101\u20136118.e13 (2021).","journal-title":"Cell"},{"key":"2811_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","volume":"599","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. B-cell-derived GABA elicits IL-10+ macrophages to limit antitumor immunity. Nature 599, 471\u2013476 (2021).","journal-title":"Nature"},{"key":"2811_CR17","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","volume":"189","author":"C Germain","year":"2014","unstructured":"Germain, C. et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am. J. Respir. Crit. Care Med. 189, 832\u2013844 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2811_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/imm.12554","volume":"147","author":"GW Jones","year":"2016","unstructured":"Jones, G. W. & Jones, S. A. Ectopic lymphoid follicles: inducible centers for generating antigen-specific immune responses within tissues. Immunology 147, 141\u2013151 (2016).","journal-title":"Immunology"},{"key":"2811_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-020-00092-3","volume":"12","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Prognostic value of tertiary lymphoid structure and tumor infiltrating lymphocytes in oral squamous cell carcinoma. Int. J. Oral. Sci. 12, 24 (2020).","journal-title":"Int. J. Oral. Sci."},{"key":"2811_CR20","doi-asserted-by":"publisher","first-page":"e008613","DOI":"10.1136\/jitc-2023-008613","volume":"12","author":"Y-Q Wang","year":"2024","unstructured":"Wang, Y.-Q. et al. Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study. J. Immunother. Cancer 12, e008613 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-023-00372-8","volume":"12","author":"W Ma","year":"2023","unstructured":"Ma, W. et al. Increasing cure rates of solid tumors by immune checkpoint inhibitors. Exp. Hematol. Oncol. 12, 10 (2023).","journal-title":"Exp. Hematol. Oncol."},{"key":"2811_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","volume":"21","author":"RC Larson","year":"2021","unstructured":"Larson, R. C. & Maus, M. V. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat. Rev. Cancer 21, 145\u2013161 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2811_CR23","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.ccell.2025.07.021","volume":"43","author":"A Biederst\u00e4dt","year":"2025","unstructured":"Biederst\u00e4dt, A. et al. Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency. Cancer Cell 43, 2069\u20132088.e11 (2025).","journal-title":"Cancer Cell"},{"key":"2811_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02032-9","volume":"23","author":"N Li","year":"2024","unstructured":"Li, N. et al. A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy. Mol. Cancer 23, 117 (2024).","journal-title":"Mol. Cancer"},{"key":"2811_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","volume":"20","author":"GV Sharonov","year":"2020","unstructured":"Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V. & Chudakov, D. M. B cells, plasma cells and antibody repertoires in the tumor microenvironment. Nat. Rev. Immunol. 20, 294\u2013307 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2811_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.imlet.2017.06.006","volume":"188","author":"D Ribatti","year":"2017","unstructured":"Ribatti, D. The discovery of plasma cells: An historical note. Immunol. Lett. 188, 64\u201367 (2017).","journal-title":"Immunol. Lett."},{"key":"2811_CR27","first-page":"1113","volume":"49","author":"EV Behring","year":"1890","unstructured":"Behring, E. V. Ueber das Zustandekommen der Diphtherie-Immunit\u00e4t und der Tetanus-Immunit\u00e4t bei Thieren. Dtsch. Med. Wochenschr. 49, 1113\u20131114 (1890).","journal-title":"Dtsch. Med. Wochenschr."},{"key":"2811_CR28","first-page":"1145","volume":"50","author":"EV Behring","year":"1890","unstructured":"Behring, E. V. Untersuchungen ueber das Zustandekommen der Diphtherie-Immunit\u00e4t bei Thieren. Dtsch. Med. Wochenschr. 50, 1145\u20131148 (1890).","journal-title":"Dtsch. Med. Wochenschr."},{"key":"2811_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4049\/jimmunol.58.1.1","volume":"58","author":"A Fagraeus","year":"1948","unstructured":"Fagraeus, A. The plasma cellular reaction and its relation to the formation of antibodies in vitro. J. Immunol. 58, 1\u201313 (1948).","journal-title":"J. Immunol."},{"key":"2811_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2006.03131.x","volume":"145","author":"D Ribatti","year":"2006","unstructured":"Ribatti, D., Crivellato, E. & Vacca, A. The contribution of Bruce Glick to the definition of the role played by the bursa of Fabricius in the development of the B-cell lineage. Clin. Exp. Immunol. 145, 1\u20134 (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"2811_CR31","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1126\/science.142.3596.1185","volume":"142","author":"K Hirschhorn","year":"1963","unstructured":"Hirschhorn, K., Bach, F., Kolodny, R. L., Firschein, I. L. & Hashem, N. IMMUNE RESPONSE AND MITOSIS OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO. Science 142, 1185\u20131187 (1963).","journal-title":"Science"},{"key":"2811_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4049\/jimmunol.114.2_Part_1.571","volume":"114","author":"J Cerny","year":"1975","unstructured":"Cerny, J. & Waner, E. B. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus. J. Immunol. 114, 571\u2013580 (1975).","journal-title":"J. Immunol."},{"key":"2811_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair, P. A. et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32, 129\u2013140 (2010).","journal-title":"Immunity"},{"key":"2811_CR34","first-page":"835","volume":"13","author":"EJ Foley","year":"1953","unstructured":"Foley, E. J. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res 13, 835\u2013837 (1953).","journal-title":"Cancer Res"},{"key":"2811_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1084\/jem.112.2.293","volume":"112","author":"GD Snell","year":"1960","unstructured":"Snell, G. D., Winn, H. J., Stimpfling, J. H. & Parker, S. J. DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT. J. Exp. Med. 112, 293\u2013314 (1960).","journal-title":"J. Exp. Med."},{"key":"2811_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/bjc.1973.33","volume":"27","author":"MM Roberts","year":"1973","unstructured":"Roberts, M. M., Bass, E. M., Wallace, I. W. & Stevenson, A. Local immunoglobulin production in breast cancer. Br. J. Cancer 27, 269\u2013275 (1973).","journal-title":"Br. J. Cancer"},{"key":"2811_CR37","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/343760a0","volume":"343","author":"J Hombach","year":"1990","unstructured":"Hombach, J., Tsubata, T., Leclercq, L., Stappert, H. & Reth, M. Molecular components of the B-cell antigen receptor complex of the IgM class. Nature 343, 760\u2013762 (1990).","journal-title":"Nature"},{"key":"2811_CR38","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"P van der Bruggen","year":"1991","unstructured":"van der Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643\u20131647 (1991).","journal-title":"Science"},{"key":"2811_CR39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. A human homolog of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394\u2013397 (1997).","journal-title":"Nature"},{"key":"2811_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nm0598-627","volume":"4","author":"Z Qin","year":"1998","unstructured":"Qin, Z. et al. B cells inhibit induction of T-cell-dependent tumor immunity. Nat. Med. 4, 627\u2013630 (1998).","journal-title":"Nat. Med."},{"key":"2811_CR41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/030089160008600507","volume":"86","author":"EF Murta","year":"2000","unstructured":"Murta, E. F., de Andrade, J. M., Falc\u00e3o, R. P. & Bighetti, S. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy. Tumori 86, 403\u2013407 (2000).","journal-title":"Tumori"},{"key":"2811_CR42","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature08782","volume":"464","author":"M Ammirante","year":"2010","unstructured":"Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S. & Karin, M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464, 302\u2013305 (2010).","journal-title":"Nature"},{"key":"2811_CR43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.aaf1328","volume":"352","author":"F Pucci","year":"2016","unstructured":"Pucci, F. et al. SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B-cell interactions. Science 352, 242\u2013246 (2016).","journal-title":"Science"},{"key":"2811_CR44","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2020.02.015","volume":"180","author":"Y Lu","year":"2020","unstructured":"Lu, Y. et al. Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity. Cell 180, 1081\u20131097.e24 (2020).","journal-title":"Cell"},{"key":"2811_CR45","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549\u2013555 (2020).","journal-title":"Nature"},{"key":"2811_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556\u2013560 (2020).","journal-title":"Nature"},{"key":"2811_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561\u2013565 (2020).","journal-title":"Nature"},{"key":"2811_CR48","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","volume":"591","author":"S Biswas","year":"2021","unstructured":"Biswas, S. et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature 591, 464\u2013470 (2021).","journal-title":"Nature"},{"key":"2811_CR49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06231-0","volume":"619","author":"L Bod","year":"2023","unstructured":"Bod, L. et al. B-cell-specific checkpoint molecules that regulate antitumor immunity. Nature 619, 348\u2013356 (2023).","journal-title":"Nature"},{"key":"2811_CR50","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1016\/j.cell.2024.06.038","volume":"187","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Pancancer single-cell dissection reveals phenotypically distinct B-cell subtypes. Cell 187, 4790\u20134811.e22 (2024).","journal-title":"Cell"},{"key":"2811_CR51","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.ccell.2024.09.011","volume":"42","author":"E Fitzsimons","year":"2024","unstructured":"Fitzsimons, E. et al. A pancancer single-cell RNA-seq atlas of intratumoral B cells. Cancer Cell 42, 1784\u20131797.e4 (2024).","journal-title":"Cancer Cell"},{"key":"2811_CR52","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41423-024-01211-4","volume":"21","author":"F Xiao","year":"2024","unstructured":"Xiao, F. et al. The emerging roles of B cells in cancer development. Cell. Mol. Immunol. 21, 1180\u20131182 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"2811_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri1786","volume":"6","author":"F Aloisi","year":"2006","unstructured":"Aloisi, F. & Pujol-Borrell, R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6, 205\u2013217 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"2811_CR54","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ni.3290","volume":"16","author":"S Finkin","year":"2015","unstructured":"Finkin, S. et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat. Immunol. 16, 1235\u20131244 (2015).","journal-title":"Nat. Immunol."},{"key":"2811_CR55","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","volume":"43","author":"NS Joshi","year":"2015","unstructured":"Joshi, N. S. et al. Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T-Cell Responses. Immunity 43, 579\u2013590 (2015).","journal-title":"Immunity"},{"key":"2811_CR56","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer cell 42, 1370\u20131385.e9 (2024).","journal-title":"Cancer cell"},{"key":"2811_CR57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(05)79565-9","volume":"352","author":"TN Raju","year":"1998","unstructured":"Raju, T. N. The Nobel chronicles. 1901: Emil Adolf von Behring (1854-1917). Lancet 352, 75 (1998).","journal-title":"Lancet"},{"key":"2811_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1042\/bj0730119","volume":"73","author":"P Rr","year":"1959","unstructured":"Rr, P. The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem. J. 73, 119\u2013126 (1959).","journal-title":"Biochem. J."},{"key":"2811_CR59","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1084\/jem.113.5.861","volume":"113","author":"GM Edelman","year":"1961","unstructured":"Edelman, G. M. & Poulik, M. D. Studies on structural units of the gamma-globulins. J. Exp. Med. 113, 861\u2013884 (1961).","journal-title":"J. Exp. Med."},{"key":"2811_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/eji.1830010102","volume":"1","author":"NK Jerne","year":"1971","unstructured":"Jerne, N. K. The somatic generation of immune recognition. Eur. J. Immunol. 1, 1\u20139 (1971).","journal-title":"Eur. J. Immunol."},{"key":"2811_CR61","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler, G. & Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495\u2013497 (1975).","journal-title":"Nature"},{"key":"2811_CR62","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1073\/pnas.73.10.3628","volume":"73","author":"N Hozumi","year":"1976","unstructured":"Hozumi, N. & Tonegawa, S. Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc. Natl. Acad. Sci. USA 73, 3628\u20133632 (1976).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2811_CR63","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","volume":"11","author":"Y Ishida","year":"1992","unstructured":"Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887\u20133895 (1992).","journal-title":"EMBO J."},{"key":"2811_CR64","first-page":"381","volume":"84","author":"M Mansh","year":"2011","unstructured":"Mansh, M. Ipilimumab and cancer immunotherapy: A new hope for advanced stage melanoma. Yale J. Biol. Med. 84, 381\u2013389 (2011).","journal-title":"Yale J. Biol. Med."},{"key":"2811_CR65","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1158\/1078-0432.CCR-16-0664","volume":"23","author":"A Barone","year":"2017","unstructured":"Barone, A. et al. FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma. Clin. Cancer Res. 23, 5661\u20135665 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41590-021-01078-x","volume":"23","author":"NM Weisel","year":"2022","unstructured":"Weisel, N. M. et al. Surface phenotypes of naive and memory B cells in mouse and human tissues. Nat. Immunol. 23, 135\u2013145 (2022).","journal-title":"Nat. Immunol."},{"key":"2811_CR67","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.it.2024.07.005","volume":"45","author":"T Inoue","year":"2024","unstructured":"Inoue, T., Baba, Y. & Kurosaki, T. BCR signaling in germinal center B-cell selection. Trends Immunol. 45, 693\u2013704 (2024).","journal-title":"Trends Immunol."},{"key":"2811_CR68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","volume":"20","author":"M Akkaya","year":"2020","unstructured":"Akkaya, M., Kwak, K. & Pierce, S. K. B-cell memory: Building two walls of protection against pathogens. Nat. Rev. Immunol. 20, 229\u2013238 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2811_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/imr.12988","volume":"303","author":"S Trezise","year":"2021","unstructured":"Trezise, S. & Nutt, S. L. The gene regulatory network controlling plasma cell function. Immunol. Rev. 303, 23\u201334 (2021).","journal-title":"Immunol. Rev."},{"key":"2811_CR70","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/eji.201847517","volume":"49","author":"J Tellier","year":"2019","unstructured":"Tellier, J. & Nutt, S. L. Plasma cells: The programming of an antibody-secreting machine. Eur. J. Immunol. 49, 30\u201337 (2019).","journal-title":"Eur. J. Immunol."},{"key":"2811_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s44276-025-00146-1","volume":"3","author":"A Hegoburu","year":"2025","unstructured":"Hegoburu, A., Amer, M., Frizelle, F. & Purcell, R. B cells and tertiary lymphoid structures in cancer therapy response. BJC Rep. 3, 40 (2025).","journal-title":"BJC Rep."},{"key":"2811_CR72","doi-asserted-by":"publisher","first-page":"582657","DOI":"10.3389\/fimmu.2020.582657","volume":"11","author":"J Shang","year":"2020","unstructured":"Shang, J., Zha, H. & Sun, Y. Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer. Front. Immunol. 11, 582657 (2020).","journal-title":"Front. Immunol."},{"key":"2811_CR73","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10875-012-9677-0","volume":"32","author":"M Visentini","year":"2012","unstructured":"Visentini, M. et al. Persistence of a large population of exhausted monoclonal B cells in mixed cryoglobuliemia after the eradication of hepatitis C virus infection. J. Clin. Immunol. 32, 729\u2013735 (2012).","journal-title":"J. Clin. Immunol."},{"key":"2811_CR74","doi-asserted-by":"publisher","first-page":"110257","DOI":"10.1016\/j.intimp.2023.110257","volume":"120","author":"X Zhao","year":"2023","unstructured":"Zhao, X., Zhang, H., Han, Y., Fang, C. & Liu, J. Navigating the immunometabolic heterogeneity of B cells in murine hepatocellular carcinoma at single cell resolution. Int. Immunopharmacol. 120, 110257 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR75","doi-asserted-by":"publisher","first-page":"1363176","DOI":"10.3389\/fimmu.2024.1363176","volume":"15","author":"N Rodr\u00edguez-Zhurbenko","year":"2024","unstructured":"Rodr\u00edguez-Zhurbenko, N. & Hern\u00e1ndez, A. M. The role of B-1 cells in cancer progression and anti-tumor immunity. Front. Immunol. 15, 1363176 (2024).","journal-title":"Front. Immunol."},{"key":"2811_CR76","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"2811_CR77","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1158\/2159-8290.CD-21-1658","volume":"12","author":"D Hao","year":"2022","unstructured":"Hao, D. et al. The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma. Cancer Discov. 12, 2626\u20132645 (2022).","journal-title":"Cancer Discov."},{"key":"2811_CR78","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202217341","volume":"15","author":"MKY Chung","year":"2023","unstructured":"Chung, M. K. Y. et al. Functions of double-negative B cells in autoimmune diseases, infections, and cancers. EMBO Mol. Med. 15, e17341 (2023).","journal-title":"EMBO Mol. Med."},{"key":"2811_CR79","doi-asserted-by":"publisher","first-page":"744889","DOI":"10.3389\/fonc.2021.744889","volume":"11","author":"L Gong","year":"2021","unstructured":"Gong, L. et al. The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment. Front. Oncol. 11, 744889 (2021).","journal-title":"Front. Oncol."},{"key":"2811_CR80","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/imm.13568","volume":"168","author":"J Xia","year":"2023","unstructured":"Xia, J. et al. Single-cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer. Immunology 168, 135\u2013151 (2023).","journal-title":"Immunology"},{"key":"2811_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39042-y","volume":"14","author":"S Crescioli","year":"2023","unstructured":"Crescioli, S. et al. B-cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma. Nat. Commun. 14, 3378 (2023).","journal-title":"Nat. Commun."},{"key":"2811_CR82","doi-asserted-by":"publisher","first-page":"216664","DOI":"10.1016\/j.canlet.2024.216664","volume":"584","author":"L Ji","year":"2024","unstructured":"Ji, L. et al. scRNA-seq of colorectal cancer shows regional immune atlas with the function of CD20+ B cells. Cancer Lett. 584, 216664 (2024).","journal-title":"Cancer Lett."},{"key":"2811_CR83","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan, M. et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55, 527\u2013541.e5 (2022).","journal-title":"Immunity"},{"key":"2811_CR84","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/2326-6066.CIR-23-1114","volume":"12","author":"P Yolmo","year":"2024","unstructured":"Yolmo, P. et al. Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Gu\u00e9rin in Non-Muscle Invasive Bladder Cancer. Cancer Immunol. Res. 12, 1320\u20131339 (2024).","journal-title":"Cancer Immunol. Res."},{"key":"2811_CR85","doi-asserted-by":"publisher","first-page":"101885","DOI":"10.1016\/j.tranon.2024.101885","volume":"41","author":"C Chen","year":"2024","unstructured":"Chen, C., Zhang, Y., Wu, X. & Shen, J. The role of tertiary lymphoid structure and B cells in nasopharyngeal carcinoma: Based on bioinformatics and experimental verification. Transl. Oncol. 41, 101885 (2024).","journal-title":"Transl. Oncol."},{"key":"2811_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22300-2","volume":"12","author":"Q Hu","year":"2021","unstructured":"Hu, Q. et al. Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling. Nat. Commun. 12, 2186 (2021).","journal-title":"Nat. Commun."},{"key":"2811_CR87","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.4251\/wjgo.v16.i6.2683","volume":"16","author":"J-P Zhang","year":"2024","unstructured":"Zhang, J.-P., Yan, B.-Z., Liu, J. & Wang, W. Action of circulating and infiltrating B cells in the immune microenvironment of colorectal cancer by single-cell sequencing analysis. World J. Gastrointest. Oncol. 16, 2683\u20132696 (2024).","journal-title":"World J. Gastrointest. Oncol."},{"key":"2811_CR88","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/HEP.0000000000001191","volume":"82","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Genomic and the tumor microenvironment heterogeneity in multifocal hepatocellular carcinoma. Hepatology 82, 582\u2013598 (2025).","journal-title":"Hepatology"},{"key":"2811_CR89","doi-asserted-by":"publisher","first-page":"981","DOI":"10.20892\/j.issn.2095-3941.2021.0029","volume":"18","author":"H Zhao","year":"2021","unstructured":"Zhao, H., Wang, H., Zhou, Q. & Ren, X. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies. Cancer Biol. Med. 18, 981\u2013991 (2021).","journal-title":"Cancer Biol. Med."},{"key":"2811_CR90","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00432-024-05672-y","volume":"150","author":"H Peng","year":"2024","unstructured":"Peng, H. et al. Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies. J. Cancer Res. Clin. Oncol. 150, 153 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2811_CR91","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.humpath.2016.03.022","volume":"54","author":"K Garg","year":"2016","unstructured":"Garg, K. et al. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome. Hum. Pathol. 54, 157\u201364 (2016).","journal-title":"Hum. Pathol."},{"key":"2811_CR92","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00262-011-1071-x","volume":"60","author":"A Lad\u00e1nyi","year":"2011","unstructured":"Lad\u00e1nyi, A. et al. Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol. Immunother. 60, 1729\u20131738 (2011).","journal-title":"Cancer Immunol. Immunother."},{"key":"2811_CR93","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccell.2022.02.002","volume":"40","author":"NS Patil","year":"2022","unstructured":"Patil, N. S. et al. Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer. Cancer Cell 40, 289\u2013300.e4 (2022).","journal-title":"Cancer Cell"},{"key":"2811_CR94","doi-asserted-by":"publisher","first-page":"e001136","DOI":"10.1136\/jitc-2020-001136","volume":"9","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer. J. Immunother. Cancer 9, e001136 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12830","volume":"91","author":"AA Zirakzadeh","year":"2020","unstructured":"Zirakzadeh, A. A. et al. Tumor-associated B cells in urothelial urinary bladder cancer. Scand. J. Immunol. 91, e12830 (2020).","journal-title":"Scand. J. Immunol."},{"key":"2811_CR96","doi-asserted-by":"publisher","first-page":"216981","DOI":"10.1016\/j.canlet.2024.216981","volume":"594","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B-cell gene set. Cancer Lett. 594, 216981 (2024).","journal-title":"Cancer Lett."},{"key":"2811_CR97","doi-asserted-by":"publisher","DOI":"10.1172\/JCI179501","volume":"134","author":"BH Nelson","year":"2024","unstructured":"Nelson, B. H. et al. Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer. J. Clin. Invest. 134, e179501 (2024).","journal-title":"J. Clin. Invest."},{"key":"2811_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23355-x","volume":"12","author":"AT Ruffin","year":"2021","unstructured":"Ruffin, A. T. et al. B-cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat. Commun. 12, 3349 (2021).","journal-title":"Nat. Commun."},{"key":"2811_CR99","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41586-020-2931-3","volume":"597","author":"A Wieland","year":"2021","unstructured":"Wieland, A. et al. Defining HPV-specific B-cell responses in patients with head and neck cancer. Nature 597, 274\u2013278 (2021).","journal-title":"Nature"},{"key":"2811_CR100","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","volume":"18","author":"JS Nielsen","year":"2012","unstructured":"Nielsen, J. S. et al. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin. Cancer Res. 18, 3281\u20133292 (2012).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR101","doi-asserted-by":"publisher","first-page":"12890","DOI":"10.3390\/ijms241612890","volume":"24","author":"C Su","year":"2023","unstructured":"Su, C. et al. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing. Int. J. Mol. Sci. 24, 12890 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2811_CR102","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ccell.2023.06.005","volume":"41","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell 41, 1407\u20131426.e9 (2023).","journal-title":"Cancer Cell"},{"key":"2811_CR103","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00428-016-1914-0","volume":"468","author":"K Miyatani","year":"2016","unstructured":"Miyatani, K. et al. A high number of IgG4-positive cells in gastric cancer tissue is associated with tumor progression and poor prognosis. Virchows Arch. 468, 549\u2013557 (2016).","journal-title":"Virchows Arch."},{"key":"2811_CR104","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar, V. et al. Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer. Cancer Discov. 12, 670\u2013691 (2022).","journal-title":"Cancer Discov."},{"key":"2811_CR105","doi-asserted-by":"publisher","first-page":"848","DOI":"10.21037\/jgo.2016.11.07","volume":"7","author":"R Fristedt","year":"2016","unstructured":"Fristedt, R. et al. Prognostic impact of tumor-associated B cells and plasma cells in esophageal and gastric adenocarcinoma. J. Gastrointest. Oncol. 7, 848\u2013859 (2016).","journal-title":"J. Gastrointest. Oncol."},{"key":"2811_CR106","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12026-020-09167-z","volume":"69","author":"Z Ni","year":"2021","unstructured":"Ni, Z. et al. Tumor-infiltrating B-cell is associated with the control of progression of gastric cancer. Immunol. Res. 69, 43\u201352 (2021).","journal-title":"Immunol. Res."},{"key":"2811_CR107","doi-asserted-by":"publisher","first-page":"110622","DOI":"10.1016\/j.vetimm.2023.110622","volume":"262","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Transcriptomic analysis reveals immune infiltration status and potential biomarkers of canine colorectal cancer. Vet. Immunol. Immunopathol. 262, 110622 (2023).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"2811_CR108","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00384-023-04322-y","volume":"38","author":"H Karjalainen","year":"2023","unstructured":"Karjalainen, H., Sirni\u00f6, P., Tuomisto, A., M\u00e4kinen, M. J. & V\u00e4yrynen, J. P. A prognostic score based on B-cell and plasma cell densities compared to T-cell densities in colorectal cancer. Int. J. Colorectal Dis. 38, 47 (2023).","journal-title":"Int. J. Colorectal Dis."},{"key":"2811_CR109","doi-asserted-by":"publisher","first-page":"113752","DOI":"10.1016\/j.intimp.2024.113752","volume":"145","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Integrating scRNA-seq and Visium HD for the analysis of the tumor microenvironment in the progression of colorectal cancer. Int. Immunopharmacol. 145, 113752 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1404-z","volume":"16","author":"SM Centuori","year":"2018","unstructured":"Centuori, S. M. et al. Double-negative (CD27-IgD-) B cells are expanded in NSCLC and inversely correlate with affinity-matured B-cell populations. J. Transl. Med. 16, 30 (2018).","journal-title":"J. Transl. Med."},{"key":"2811_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-025-00414-7","volume":"162","author":"F Zhong","year":"2025","unstructured":"Zhong, F. et al. Infiltrating B-cell subtypes and associated hub genes in nasopharyngeal carcinoma identified from integrated single-cell, bulk RNA-sequencing, and immunohistochemical data. Hereditas 162, 48 (2025).","journal-title":"Hereditas"},{"key":"2811_CR112","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh1315","volume":"17","author":"AT Ruffin","year":"2025","unstructured":"Ruffin, A. T. et al. Dysfunctional CD11c-CD21- extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer. Sci. Transl. Med. 17, eadh1315 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2811_CR113","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1900635","volume":"10","author":"A J Gunderson","year":"2021","unstructured":"J Gunderson, A. et al. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. Oncoimmunology 10, 1900635 (2021).","journal-title":"Oncoimmunology"},{"key":"2811_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04947-9","volume":"22","author":"M Gui","year":"2024","unstructured":"Gui, M. et al. Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors. J. Transl. Med. 22, 206 (2024).","journal-title":"J. Transl. Med."},{"key":"2811_CR115","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/25785826.2025.2454045","volume":"48","author":"H Asashima","year":"2025","unstructured":"Asashima, H., Akao, S. & Matsumoto, I. Emerging roles of checkpoint molecules on B cells. Immunol. Med. 48, 171\u2013182 (2025).","journal-title":"Immunol. Med."},{"key":"2811_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01174-5","volume":"21","author":"YJ Jung","year":"2023","unstructured":"Jung, Y. J. et al. Effect of IL-10-producing B cells in peripheral blood and tumor tissue on gastric cancer. Cell. Commun. Signal. 21, 320 (2023).","journal-title":"Cell. Commun. Signal."},{"key":"2811_CR117","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/ana.26784","volume":"94","author":"A Vogrig","year":"2023","unstructured":"Vogrig, A. et al. Different genetic signatures of small-cell lung cancer characterize anti-GABAB R and anti-Hu paraneoplastic neurological syndromes. Ann. Neurol. 94, 1102\u20131115 (2023).","journal-title":"Ann. Neurol."},{"key":"2811_CR118","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.imbio.2013.04.017","volume":"218","author":"P Xander","year":"2013","unstructured":"Xander, P. et al. Crosstalk between B16 melanoma cells and B-1 lymphocytes induces global changes in tumor cell gene expression. Immunobiology 218, 1293\u20131303 (2013).","journal-title":"Immunobiology"},{"key":"2811_CR119","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12020-020-02478-z","volume":"70","author":"P Marques","year":"2020","unstructured":"Marques, P. et al. The role of the tumor microenvironment in the angiogenesis of pituitary tumors. Endocrine 70, 593\u2013606 (2020).","journal-title":"Endocrine"},{"key":"2811_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02231-y","volume":"24","author":"Y Deng","year":"2025","unstructured":"Deng, Y. et al. Comprehensive single-cell atlas of colorectal neuroendocrine tumors with liver metastases: unraveling tumor microenvironment heterogeneity between primary lesions and metastases. Mol. Cancer 24, 28 (2025).","journal-title":"Mol. Cancer"},{"key":"2811_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00922-x","volume":"13","author":"S Olbrecht","year":"2021","unstructured":"Olbrecht, S. et al. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification. Genome Med. 13, 111 (2021).","journal-title":"Genome Med."},{"key":"2811_CR122","doi-asserted-by":"publisher","first-page":"e005539","DOI":"10.1136\/jitc-2022-005539","volume":"11","author":"M He","year":"2023","unstructured":"He, M. et al. Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer. J. Immunother. Cancer 11, e005539 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR123","volume":"9","author":"Z Ou","year":"2022","unstructured":"Ou, Z. et al. Single-nucleus RNA sequencing and spatial transcriptomics reveal the immunological microenvironment of cervical squamous cell carcinoma. Adv. Sci. (Weinh.) 9, e2203040 (2022).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2811_CR124","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2104426","volume":"11","author":"RJ Harris","year":"2022","unstructured":"Harris, R. J. et al. Enriched circulating and tumor-resident TGF-\u03b2+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs. Oncoimmunology 11, 2104426 (2022).","journal-title":"Oncoimmunology"},{"key":"2811_CR125","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41422-020-0374-x","volume":"30","author":"YP Chen","year":"2020","unstructured":"Chen, Y. P. et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 30, 1024\u20131042 (2020).","journal-title":"Cell Res."},{"key":"2811_CR126","doi-asserted-by":"publisher","first-page":"e006939","DOI":"10.1136\/jitc-2023-006939","volume":"11","author":"X Yin","year":"2023","unstructured":"Yin, X. et al. Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy. J. Immunother. Cancer 11, e006939 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR127","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","volume":"24","author":"MCA Wouters","year":"2018","unstructured":"Wouters, M. C. A. & Nelson, B. H. Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer. Clin. Cancer Res. 24, 6125\u20136135 (2018).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR128","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu, B., Zhang, B., Li, B., Wu, H. & Jiang, M. Cold and hot tumors: From molecular mechanisms to targeted therapy. Signal Transduct. Target Ther. 9, 274 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2811_CR129","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/hep.29904","volume":"68","author":"Y Kurebayashi","year":"2018","unstructured":"Kurebayashi, Y. et al. Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification. Hepatology 68, 1025\u20131041 (2018).","journal-title":"Hepatology"},{"key":"2811_CR130","doi-asserted-by":"publisher","first-page":"108340","DOI":"10.1016\/j.intimp.2021.108340","volume":"101","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma. Int. Immunopharmacol. 101, 108340 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR131","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","volume":"19","author":"JY Shi","year":"2013","unstructured":"Shi, J. Y. et al. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clin. Cancer Res. 19, 5994\u20136005 (2013).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR132","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/1751-2980.12997","volume":"22","author":"X Li","year":"2021","unstructured":"Li, X. et al. C-C chemokine hepatocellular carcinoma motif ligand 5-deficiency promotes hepatocellular carcinoma progression by affecting B-cell recruitment. J. Dig. Dis. 22, 433\u2013441 (2021).","journal-title":"J. Dig. Dis."},{"key":"2811_CR133","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.21037\/jgo-22-717","volume":"13","author":"J Zou","year":"2022","unstructured":"Zou, J. et al. The role of tumor-infiltrating B cells in the tumor microenvironment of hepatocellular carcinoma and its prognostic value: A bioinformatics analysis. J. Gastrointest. Oncol. 13, 1959\u20131966 (2022).","journal-title":"J. Gastrointest. Oncol."},{"key":"2811_CR134","doi-asserted-by":"publisher","first-page":"647209","DOI":"10.3389\/fimmu.2021.647209","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. PNOC expressed by B cells in cholangiocarcinoma was survival related and LAIR2 Could Be a T-cell exhaustion biomarker in tumor microenvironment: Characterization of immune microenvironment combining single-cell and bulk sequencing technology. Front. Immunol. 12, 647209 (2021).","journal-title":"Front. Immunol."},{"key":"2811_CR135","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-011-1620-1","volume":"132","author":"SMA Mahmoud","year":"2012","unstructured":"Mahmoud, S. M. A. et al. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res. Treat. 132, 545\u2013553 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"2811_CR136","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yexcr.2017.10.013","volume":"361","author":"S Zhu","year":"2017","unstructured":"Zhu, S. et al. CD21lo\/medCD27+ proinflammatory B cells are enriched in breast cancer patients and promote antitumor T-cell responses. Exp. Cell Res. 361, 149\u2013154 (2017).","journal-title":"Exp. Cell Res."},{"key":"2811_CR137","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0198-y","volume":"31","author":"T Xu","year":"2014","unstructured":"Xu, T. et al. Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma. Med. Oncol. 31, 198 (2014).","journal-title":"Med. Oncol."},{"key":"2811_CR138","doi-asserted-by":"publisher","first-page":"860900","DOI":"10.3389\/fonc.2022.860900","volume":"12","author":"E Wei","year":"2022","unstructured":"Wei, E. et al. Integration of scRNA-Seq and TCGA RNA-Seq to Analyze the Heterogeneity of HPV+ and HPV- Cervical Cancer Immune Cells and Establish Molecular Risk Models. Front. Oncol. 12, 860900 (2022).","journal-title":"Front. Oncol."},{"key":"2811_CR139","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00428-021-03137-y","volume":"479","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma. Virchows Arch. 479, 947\u2013959 (2021).","journal-title":"Virchows Arch."},{"key":"2811_CR140","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.intimp.2017.10.009","volume":"53","author":"Y Jin","year":"2017","unstructured":"Jin, Y. et al. CXCR5+CD8+ T cells could induce the death of tumor cells in HBV-related hepatocellular carcinoma. Int. Immunopharmacol. 53, 42\u201348 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR141","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/dna.2016.3571","volume":"36","author":"H Jiang","year":"2017","unstructured":"Jiang, H. et al. CXCR5+ CD8+ T cells indirectly offer B-cell help and are inversely correlated with viral load in chronic hepatitis B infection. DNA Cell Biol. 36, 321\u2013327 (2017).","journal-title":"DNA Cell Biol."},{"key":"2811_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12160-2","volume":"10","author":"J Griss","year":"2019","unstructured":"Griss, J. et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat. Commun. 10, 4186 (2019).","journal-title":"Nat. Commun."},{"key":"2811_CR143","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.molimm.2019.07.019","volume":"114","author":"M Arabpour","year":"2019","unstructured":"Arabpour, M., Rasolmali, R., Talei, A.-R., Mehdipour, F. & Ghaderi, A. Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes. Mol. Immunol. 114, 172\u2013178 (2019).","journal-title":"Mol. Immunol."},{"key":"2811_CR144","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/eji.201444625","volume":"45","author":"H Tao","year":"2015","unstructured":"Tao, H. et al. Antitumor effector B cells directly kill tumor cells via the Fas\/FasL pathway and are regulated by IL-10. Eur. J. Immunol. 45, 999\u20131009 (2015).","journal-title":"Eur. J. Immunol."},{"key":"2811_CR145","doi-asserted-by":"publisher","first-page":"1516793","DOI":"10.3389\/fimmu.2025.1516793","volume":"16","author":"P Rodrigues-Santos","year":"2025","unstructured":"Rodrigues-Santos, P. et al. Immune monitoring of trabectedin therapy in refractory soft tissue sarcoma patients - the IMMUNYON study. Front. Immunol. 16, 1516793 (2025).","journal-title":"Front. Immunol."},{"key":"2811_CR146","doi-asserted-by":"publisher","first-page":"722451","DOI":"10.3389\/fimmu.2021.722451","volume":"12","author":"V Shibad","year":"2021","unstructured":"Shibad, V. et al. L2pB1 cells contribute to tumor growth inhibition. Front. Immunol. 12, 722451 (2021).","journal-title":"Front. Immunol."},{"key":"2811_CR147","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3389\/fimmu.2020.00538","volume":"11","author":"ND Ebelt","year":"2020","unstructured":"Ebelt, N. D., Zuniga, E., Johnson, B. L., Diamond, D. J. & Manuel, E. R. 5-azacytidine potentiates anti-tumor immunity in a model of pancreatic ductal adenocarcinoma. Front. Immunol. 11, 538 (2020).","journal-title":"Front. Immunol."},{"key":"2811_CR148","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3389\/fimmu.2018.02660","volume":"9","author":"S Garaud","year":"2018","unstructured":"Garaud, S. et al. Antigen specificity and clinical significance of IgG and IgA autoantibodies produced in situ by tumor-infiltrating B cells in breast cancer. Front. Immunol. 9, 2660 (2018).","journal-title":"Front. Immunol."},{"key":"2811_CR149","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2019.11.003","volume":"41","author":"Y Liu","year":"2020","unstructured":"Liu, Y. & Zheng, P. Preserving the CTLA-4 checkpoint for safer and more effective cancer immunotherapy. Trends Pharmacol. Sci. 41, 4\u201312 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"2811_CR150","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.3390\/ijms22158030","volume":"22","author":"H Bareke","year":"2021","unstructured":"Bareke, H. et al. Autoimmune responses in oncology: Causes and significance. Int. J. Mol. Sci. 22, 8030 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2811_CR151","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/gutjnl-2021-325808","volume":"72","author":"KM Sullivan","year":"2023","unstructured":"Sullivan, K. M. et al. Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Gut 72, 325\u2013337 (2023).","journal-title":"Gut"},{"key":"2811_CR152","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","volume":"185","author":"RD Mazor","year":"2022","unstructured":"Mazor, R. D. et al. Tumor-reactive antibodies evolve from nonbinding and autoreactive precursors. Cell 185, 1208\u20131222.e21 (2022).","journal-title":"Cell"},{"key":"2811_CR153","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ccell.2022.03.011","volume":"40","author":"AC Banville","year":"2022","unstructured":"Banville, A. C. & Nelson, B. H. Breaching B-cell tolerance in the tumor microenvironment. Cancer Cell 40, 356\u2013358 (2022).","journal-title":"Cancer Cell"},{"key":"2811_CR154","first-page":"029","volume":"4","author":"WR Liu","year":"2021","unstructured":"Liu, W. R. & Fisher, D. E. Epitope spreading and the efficacy of immune checkpoint inhibition in cancer. Int. J. Oncol. Res. 4, 029 (2021).","journal-title":"Int. J. Oncol. Res."},{"key":"2811_CR155","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1158\/2326-6066.CIR-20-0949","volume":"9","author":"K Wennhold","year":"2021","unstructured":"Wennhold, K. et al. CD86+ antigen-presenting B cells are increased in cancer, localize in tertiary lymphoid structures, and induce specific T-cell responses. Cancer Immunol. Res. 9, 1098\u20131108 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"2811_CR156","doi-asserted-by":"publisher","first-page":"e005200","DOI":"10.1136\/jitc-2022-005200","volume":"10","author":"M Thelen","year":"2022","unstructured":"Thelen, M. et al. Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells. J. Immunother. Cancer 10, e005200 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR157","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","volume":"2","author":"CL Vanderlugt","year":"2002","unstructured":"Vanderlugt, C. L. & Miller, S. D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2, 85\u201395 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"2811_CR158","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.4049\/jimmunol.0803742","volume":"182","author":"MM Seavey","year":"2009","unstructured":"Seavey, M. M., Maciag, P. C., Al-Rawi, N., Sewell, D. & Paterson, Y. An anti-vascular endothelial growth factor receptor 2\/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2\/neu+ breast tumors in a mouse model. J. Immunol. 182, 5537\u20135546 (2009).","journal-title":"J. Immunol."},{"key":"2811_CR159","doi-asserted-by":"publisher","first-page":"1204777","DOI":"10.3389\/fimmu.2023.1204777","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis. Front. Immunol. 14, 1204777 (2023).","journal-title":"Front. Immunol."},{"key":"2811_CR160","doi-asserted-by":"publisher","first-page":"8793","DOI":"10.3390\/curroncol30100634","volume":"30","author":"J P\u00e9rez-Hern\u00e1ndez","year":"2023","unstructured":"P\u00e9rez-Hern\u00e1ndez, J. et al. Autoantibody diversity is augmented in women with breast cancer and is related to the stage of the disease. Curr. Oncol. 30, 8793\u20138804 (2023).","journal-title":"Curr. Oncol."},{"key":"2811_CR161","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3390\/ijms24021411","volume":"24","author":"L Milchram","year":"2023","unstructured":"Milchram, L. et al. Antibody profiling and in silico functional analysis of differentially reactive antibody signatures of glioblastomas and meningiomas. Int. J. Mol. Sci. 24, 1411 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2811_CR162","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/acs.jproteome.3c00579","volume":"23","author":"T Li","year":"2024","unstructured":"Li, T. et al. hccTAAb Atlas: An integrated knowledge database for tumor-associated autoantibodies in hepatocellular carcinoma. J. Proteome Res. 23, 728\u2013737 (2024).","journal-title":"J. Proteome Res."},{"key":"2811_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30576","volume":"10","author":"K Hu","year":"2024","unstructured":"Hu, K. et al. Clinical application of serum seven tumor-associated autoantibodies in patients with pulmonary nodules. Heliyon 10, e30576 (2024).","journal-title":"Heliyon"},{"key":"2811_CR164","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/ijc.34334","volume":"152","author":"L Zhuang","year":"2023","unstructured":"Zhuang, L. et al. Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma. Int. J. Cancer 152, 1013\u20131024 (2023).","journal-title":"Int. J. Cancer"},{"key":"2811_CR165","doi-asserted-by":"publisher","first-page":"1022331","DOI":"10.3389\/fonc.2023.1022331","volume":"13","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer. Front. Oncol. 13, 1022331 (2023).","journal-title":"Front. Oncol."},{"key":"2811_CR166","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202407131","volume":"63","author":"F Corzana","year":"2024","unstructured":"Corzana, F. et al. Detection of tumor-associated autoantibodies in the sera of pancreatic cancer patients using engineered muc1 glycopeptide nanoparticle probes. Angew. Chem. Int. Ed. Engl. 63, e202407131 (2024).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2811_CR167","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1158\/2767-9764.CRC-23-0289","volume":"3","author":"AV Vylegzhanina","year":"2023","unstructured":"Vylegzhanina, A. V. et al. Cancer relevance of circulating antibodies against LINE-1 antigens in humans. Cancer Res. Commun. 3, 2256\u20132267 (2023).","journal-title":"Cancer Res. Commun."},{"key":"2811_CR168","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/1878-0261.13371","volume":"17","author":"Q Yang","year":"2023","unstructured":"Yang, Q. et al. Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma. Mol. Oncol. 17, 887\u2013900 (2023).","journal-title":"Mol. Oncol."},{"key":"2811_CR169","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1016\/j.clon.2023.06.014","volume":"35","author":"G Sun","year":"2023","unstructured":"Sun, G. et al. Using proteome microarray and gene expression omnibus database to screen tumor-associated antigens to construct the optimal diagnostic model of esophageal squamous cell carcinoma. Clin. Oncol. (R. Coll. Radiol.) 35, e582\u2013e592 (2023).","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"2811_CR170","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/1759-7714.14772","volume":"14","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small cell lung cancer. Thorac. Cancer 14, 497\u2013505 (2023).","journal-title":"Thorac. Cancer"},{"key":"2811_CR171","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12890-024-03060-3","volume":"24","author":"H Ma","year":"2024","unstructured":"Ma, H., Wu, T., Zhang, Q. & Ding, Q. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer. BMC Pulm. Med. 24, 250 (2024).","journal-title":"BMC Pulm. Med."},{"key":"2811_CR172","doi-asserted-by":"publisher","first-page":"153303382412934","DOI":"10.1177\/15330338241293490","volume":"23","author":"F Ren","year":"2024","unstructured":"Ren, F. et al. Clinical value of seven autoantibodies against tumor-associated antigens and tumor markers in lung cancer patients: A retrospective analysis from a single institution. Technol. Cancer Res. Treat. 23, 15330338241293490 (2024).","journal-title":"Technol. Cancer Res. Treat."},{"key":"2811_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120167","volume":"569","author":"K Xiao","year":"2025","unstructured":"Xiao, K. et al. The value of serum tumor-associated autoantibodies in screening and diagnosis of gastric cancer. Clin. Chim. Acta 569, 120167 (2025).","journal-title":"Clin. Chim. Acta"},{"key":"2811_CR174","doi-asserted-by":"publisher","first-page":"8369","DOI":"10.1007\/s00432-023-04732-z","volume":"149","author":"Q Zhu","year":"2023","unstructured":"Zhu, Q. et al. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion. J. Cancer Res. Clin. Oncol. 149, 8369\u20138378 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2811_CR175","doi-asserted-by":"publisher","first-page":"109206","DOI":"10.1016\/j.clim.2022.109206","volume":"246","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer. Clin. Immunol. 246, 109206 (2023).","journal-title":"Clin. Immunol."},{"key":"2811_CR176","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.3390\/ijms24043721","volume":"24","author":"C Qiu","year":"2023","unstructured":"Qiu, C. et al. Autoantibodies to PAX5, PTCH1, and GNA11 as serological biomarkers in the detection of hepatocellular carcinoma in hispanic Americans. Int. J. Mol. Sci. 24, 3721 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2811_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100872","volume":"23","author":"W Hao","year":"2024","unstructured":"Hao, W. et al. Screening of cancer-specific biomarkers for Hepatitis B-related hepatocellular carcinoma based on a proteome microarray. Mol. Cell. Proteom. 23, 100872 (2024).","journal-title":"Mol. Cell. Proteom."},{"key":"2811_CR178","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17494","volume":"12","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma. PeerJ 12, e17494 (2024).","journal-title":"PeerJ"},{"key":"2811_CR179","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/1940-6207.CAPR-23-0311","volume":"17","author":"Y Shen","year":"2024","unstructured":"Shen, Y. et al. Combination of an autoantibody panel and alpha-fetoprotein for early detection of hepatitis B virus-associated hepatocellular carcinoma. Cancer Prev. Res. (Phila.) 17, 227\u2013235 (2024).","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"2811_CR180","doi-asserted-by":"publisher","first-page":"1167691","DOI":"10.3389\/fonc.2023.1167691","volume":"13","author":"R Abdulla","year":"2023","unstructured":"Abdulla, R., Devasia Puthenpurackal, J., Pinto, S. M., Rekha, P. D. & Subbannayya, Y. Serum autoantibody profiling of oral squamous cell carcinoma patients reveals NUBP2 as a potential diagnostic marker. Front. Oncol. 13, 1167691 (2023).","journal-title":"Front. Oncol."},{"key":"2811_CR181","doi-asserted-by":"publisher","first-page":"1166894","DOI":"10.3389\/fonc.2023.1166894","volume":"13","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Early detection of lung cancer in a real-world cohort via tumor-associated immune autoantibody and imaging combination. Front. Oncol. 13, 1166894 (2023).","journal-title":"Front. Oncol."},{"key":"2811_CR182","doi-asserted-by":"publisher","first-page":"1161489","DOI":"10.3389\/fonc.2023.1161489","volume":"13","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection. Front. Oncol. 13, 1161489 (2023).","journal-title":"Front. Oncol."},{"key":"2811_CR183","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s12672-025-02167-1","volume":"16","author":"S Tabaei","year":"2025","unstructured":"Tabaei, S. et al. Investigation of new autoantibodies in urothelial bladder cancer for biomarker discovery using immunoproteomics. Discov. Oncol. 16, 436 (2025).","journal-title":"Discov. Oncol."},{"key":"2811_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117727","volume":"554","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Proteome microarray identifies autoantibody biomarkers for diagnosis of hepatitis B-related hepatocellular carcinoma. Clin. Chim. Acta 554, 117727 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"2811_CR185","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.advms.2025.01.004","volume":"70","author":"J Wang","year":"2025","unstructured":"Wang, J., Liu, S. & Zhang, X. Investigation of circulating natural autoantibodies against ANXA1 and MYC as potential biomarkers in hepatocellular carcinoma. Adv. Med. Sci. 70, 136\u2013140 (2025).","journal-title":"Adv. Med. Sci."},{"key":"2811_CR186","doi-asserted-by":"publisher","first-page":"1518431","DOI":"10.3389\/fimmu.2024.1518431","volume":"15","author":"S Zhou","year":"2024","unstructured":"Zhou, S. et al. Diagnostic value of multitumor-associated autoantibody expression in esophageal squamous cell carcinoma and correlation of clinical features. Front. Immunol. 15, 1518431 (2024).","journal-title":"Front. Immunol."},{"key":"2811_CR187","doi-asserted-by":"publisher","first-page":"1538071","DOI":"10.3389\/fimmu.2025.1538071","volume":"16","author":"Y Ye","year":"2025","unstructured":"Ye, Y., Huang, Y. & Pan, J. Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer. Front. Immunol. 16, 1538071 (2025).","journal-title":"Front. Immunol."},{"key":"2811_CR188","doi-asserted-by":"publisher","first-page":"1330419","DOI":"10.3389\/fonc.2024.1330419","volume":"14","author":"PWM Maimela","year":"2024","unstructured":"Maimela, P. W. M. et al. Humoral immunoprofiling identifies novel biomarkers and an immune suppressive autoantibody phenotype at the site of disease in pancreatic ductal adenocarcinoma. Front. Oncol. 14, 1330419 (2024).","journal-title":"Front. Oncol."},{"key":"2811_CR189","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/17520363.2024.2404379","volume":"18","author":"G Chen","year":"2024","unstructured":"Chen, G., Guo, P., Zhao, H., Zhao, D. & Yang, D. The clinical value of combined detection of seven lung cancer-related autoantibodies in assisting the diagnosis of non-small cell lung cancer. Biomark. Med. 18, 917\u2013925 (2024).","journal-title":"Biomark. Med."},{"key":"2811_CR190","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/cas.16011","volume":"115","author":"P-F Zhang","year":"2024","unstructured":"Zhang, P.-F. et al. Autoantibody repertoire profiling in tissue and blood identifies colorectal cancer-specific biomarkers. Cancer Sci. 115, 83\u201393 (2024).","journal-title":"Cancer Sci."},{"key":"2811_CR191","doi-asserted-by":"publisher","first-page":"2290799","DOI":"10.1080\/2162402X.2023.2290799","volume":"13","author":"TV Guy","year":"2024","unstructured":"Guy, T. V., Terry, A. M., McGuire, H. M., Shklovskaya, E. & Fazekas de St Groth, B. MHCII restriction demonstrates B cells have very limited capacity to activate tumor-specific CD4+ T cells in vivo. Oncoimmunology 13, 2290799 (2024).","journal-title":"Oncoimmunology"},{"key":"2811_CR192","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biochi.2015.06.026","volume":"116","author":"M-Z Sun","year":"2015","unstructured":"Sun, M.-Z., Cui, Y., Guo, C., Zhao, B. & Liu, S. rAdinbitor, a disintegrin from Agkistrodon halys brevicaudus stejneger, inhibits tumorigenicity of hepatocarcinoma via enhanced anti-angiogenesis and immunocompetence. Biochimie 116, 34\u201342 (2015).","journal-title":"Biochimie"},{"key":"2811_CR193","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153454","volume":"132","author":"B Yang","year":"2022","unstructured":"Yang, B. et al. An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment. J. Clin. Invest. 132, e153454 (2022).","journal-title":"J. Clin. Invest."},{"key":"2811_CR194","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1158\/2326-6066.CIR-21-0489","volume":"10","author":"IA Dyugay","year":"2022","unstructured":"Dyugay, I. A. et al. Accounting for B-cell Behavior and Sampling Bias Predicts Anti-PD-L1 Response in Bladder Cancer. Cancer Immunol. Res. 10, 343\u2013353 (2022).","journal-title":"Cancer Immunol. Res."},{"key":"2811_CR195","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200269RR","volume":"36","author":"Y Nie","year":"2022","unstructured":"Nie, Y. et al. Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma. FASEB J. 36, e22586 (2022).","journal-title":"FASEB J."},{"key":"2811_CR196","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","volume":"22","author":"DR Kroeger","year":"2016","unstructured":"Kroeger, D. R., Milne, K. & Nelson, B. H. Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer. Clin. Cancer Res. 22, 3005\u20133015 (2016).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR197","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-12-1377","volume":"72","author":"A Cipponi","year":"2012","unstructured":"Cipponi, A. et al. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res 72, 3997\u20134007 (2012).","journal-title":"Cancer Res"},{"key":"2811_CR198","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.1158\/1078-0432.CCR-24-0479","volume":"30","author":"Y Kurebayashi","year":"2024","unstructured":"Kurebayashi, Y. et al. Spatial Dynamics of T- and B-Cell Responses Predicts Clinical Outcome of Resectable and Unresectable Hepatocellular Carcinoma. Clin. Cancer Res. 30, 5666\u20135680 (2024).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR199","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/imm.13841","volume":"173","author":"J Ma","year":"2024","unstructured":"Ma, J., Deng, Y., Zhang, M. & Zhang, Q. Spatial tertiary lymphoid structures imply response to anti-PD-1 plus anlotinib in advanced non-small cell lung cancer. Immunology 173, 536\u2013551 (2024).","journal-title":"Immunology"},{"key":"2811_CR200","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s40618-023-02072-w","volume":"46","author":"Y-Y Li","year":"2023","unstructured":"Li, Y.-Y. et al. B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer. J. Endocrinol. Invest. 46, 2247\u20132256 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"2811_CR201","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.gastro.2017.09.045","volume":"154","author":"R Liu","year":"2018","unstructured":"Liu, R. et al. MicroRNAs 15A and 16-1 activate signaling pathways that mediate chemotaxis of immune regulatory B cells to colorectal tumors. Gastroenterology 154, 637\u2013651.e7 (2018).","journal-title":"Gastroenterology"},{"key":"2811_CR202","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.immuni.2022.04.017","volume":"55","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion. Immunity 55, 1067\u20131081.e8 (2022).","journal-title":"Immunity"},{"key":"2811_CR203","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cmet.2023.12.020","volume":"36","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Targeting Erbin-mitochondria axis in platelets\/megakaryocytes promotes B-cell-mediated antitumor immunity. Cell Metab. 36, 541\u2013556.e9 (2024).","journal-title":"Cell Metab."},{"key":"2811_CR204","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/imm.13819","volume":"173","author":"A Bahabayi","year":"2024","unstructured":"Bahabayi, A. et al. Expression of GPR56 reflects a hypoactivated state of circulating B cells and is downregulated in B-cell subsets in patients with early-stage lung adenocarcinoma. Immunology 173, 172\u2013184 (2024).","journal-title":"Immunology"},{"key":"2811_CR205","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10549-024-07504-6","volume":"209","author":"Z Lv","year":"2025","unstructured":"Lv, Z. et al. BAFF overexpression in triple-negative breast cancer promotes tumor growth by inducing IL-10-secreting regulatory B cells that suppress anti-tumor T-cell responses. Breast Cancer Res. Treat. 209, 405\u2013418 (2025).","journal-title":"Breast Cancer Res. Treat."},{"key":"2811_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00452-4","volume":"8","author":"R Somasundaram","year":"2017","unstructured":"Somasundaram, R. et al. Tumor-associated B cells induce tumor heterogeneity and therapy resistance. Nat. Commun. 8, 607 (2017).","journal-title":"Nat. Commun."},{"key":"2811_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113428","volume":"196","author":"RA Belderbos","year":"2024","unstructured":"Belderbos, R. A. et al. Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC. Eur. J. Cancer 196, 113428 (2024).","journal-title":"Eur. J. Cancer"},{"key":"2811_CR208","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/intimm\/dxv038","volume":"27","author":"C Mauri","year":"2015","unstructured":"Mauri, C. & Menon, M. The expanding family of regulatory B cells. Int. Immunol. 27, 479\u2013486 (2015).","journal-title":"Int. Immunol."},{"key":"2811_CR209","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","volume":"11","author":"A Kessel","year":"2012","unstructured":"Kessel, A. et al. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun. Rev. 11, 670\u2013677 (2012).","journal-title":"Autoimmun. Rev."},{"key":"2811_CR210","doi-asserted-by":"publisher","first-page":"110728","DOI":"10.1016\/j.celrep.2022.110728","volume":"39","author":"MC Glass","year":"2022","unstructured":"Glass, M. C. et al. Human IL-10-producing B cells have diverse states that are induced from multiple B-cell subsets. Cell Rep. 39, 110728 (2022).","journal-title":"Cell Rep."},{"key":"2811_CR211","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7150\/ijms.79305","volume":"20","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Aberrant alteration of peripheral B lymphocyte subsets in hepatocellular carcinoma patients. Int. J. Med. Sci. 20, 267\u2013277 (2023).","journal-title":"Int. J. Med. Sci."},{"key":"2811_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13453","volume":"7","author":"F-Z Ouyang","year":"2016","unstructured":"Ouyang, F.-Z. et al. Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma. Nat. Commun. 7, 13453 (2016).","journal-title":"Nat. Commun."},{"key":"2811_CR213","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1073\/pnas.1100994108","volume":"108","author":"T Schioppa","year":"2011","unstructured":"Schioppa, T. et al. B regulatory cells and the tumor-promoting actions of TNF-\u03b1 during squamous carcinogenesis. Proc. Natl. Acad. Sci. USA 108, 10662\u201310667 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2811_CR214","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1111\/cas.14122","volume":"110","author":"Y Mao","year":"2019","unstructured":"Mao, Y. et al. Circulating exosomes from esophageal squamous cell carcinoma mediate the generation of B10 and PD-1high Breg cells. Cancer Sci. 110, 2700\u20132710 (2019).","journal-title":"Cancer Sci."},{"key":"2811_CR215","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40425-018-0451-6","volume":"6","author":"L Ye","year":"2018","unstructured":"Ye, L. et al. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B-cell expansion. J. Immunother. Cancer 6, 145 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR216","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1158\/2159-8290.CD-15-1408","volume":"6","author":"X Xiao","year":"2016","unstructured":"Xiao, X. et al. PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression. Cancer Discov. 6, 546\u2013559 (2016).","journal-title":"Cancer Discov."},{"key":"2811_CR217","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","volume":"551","author":"S Shalapour","year":"2017","unstructured":"Shalapour, S. et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature 551, 340\u2013345 (2017).","journal-title":"Nature"},{"key":"2811_CR218","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2015.11.003","volume":"53","author":"X Zhou","year":"2016","unstructured":"Zhou, X., Su, Y.-X., Lao, X.-M., Liang, Y.-J. & Liao, G.-Q. CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells. Oral. Oncol. 53, 27\u201335 (2016).","journal-title":"Oral. Oncol."},{"key":"2811_CR219","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13046-024-03017-8","volume":"43","author":"J Zhou","year":"2024","unstructured":"Zhou, J. et al. Investigating the impact of regulatory B cells and regulatory B-cell-related genes on bladder cancer progression and immunotherapeutic sensitivity. J. Exp. Clin. Cancer Res. 43, 101 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2811_CR220","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molimm.2020.01.008","volume":"119","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. PD-L1+ regulatory B cells act as a T-cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis. Mol. Immunol. 119, 83\u201391 (2020).","journal-title":"Mol. Immunol."},{"key":"2811_CR221","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000534427","volume":"114","author":"Y Zou","year":"2024","unstructured":"Zou, Y. et al. Correlation of neuroendocrine differentiation with a distinctively suppressive immune microenvironment in gastric cancer. Neuroendocrinology 114, 192\u2013206 (2024).","journal-title":"Neuroendocrinology"},{"key":"2811_CR222","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1093\/oncolo\/oyad113","volume":"28","author":"X Wei","year":"2023","unstructured":"Wei, X. et al. Association of tumor cell metabolic subtype and immune response with the clinical course of hepatocellular carcinoma. Oncologist 28, e1031\u2013e1042 (2023).","journal-title":"Oncologist"},{"key":"2811_CR223","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","volume":"25","author":"Y Gu","year":"2019","unstructured":"Gu, Y. et al. Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG. Nat. Med. 25, 312\u2013322 (2019).","journal-title":"Nat. Med."},{"key":"2811_CR224","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/eji.200526090","volume":"35","author":"M Kisielow","year":"2005","unstructured":"Kisielow, M., Kisielow, J., Capoferri-Sollami, G. & Karjalainen, K. Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells. Eur. J. Immunol. 35, 2081\u20132088 (2005).","journal-title":"Eur. J. Immunol."},{"key":"2811_CR225","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","volume":"43","author":"W Lee","year":"2025","unstructured":"Lee, W. et al. Neutrophil extracellular traps promote premetastatic niche formation in the omentum by expanding innate-like B cells that express IL-10. Cancer Cell 43, 69\u201385.e11 (2025).","journal-title":"Cancer Cell"},{"key":"2811_CR226","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/gutjnl-2016-311739","volume":"66","author":"ST Jendrek","year":"2017","unstructured":"Jendrek, S. T. et al. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut 66, 137\u2013144 (2017).","journal-title":"Gut"},{"key":"2811_CR227","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1158\/0008-5472.CAN-23-0193","volume":"83","author":"Z Chen","year":"2023","unstructured":"Chen, Z. et al. Cross-talk between myeloid and B cells shapes the distinct microenvironments of primary and secondary liver cancer. Cancer Res 83, 3544\u20133561 (2023).","journal-title":"Cancer Res"},{"key":"2811_CR228","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1172\/JCI65579","volume":"123","author":"P Karagiannis","year":"2013","unstructured":"Karagiannis, P. et al. IgG4 subclass antibodies impair antitumor immunity in melanoma. J. Clin. Invest. 123, 1457\u20131474 (2013).","journal-title":"J. Clin. Invest."},{"key":"2811_CR229","doi-asserted-by":"publisher","first-page":"605","DOI":"10.17305\/bb.2022.8586","volume":"23","author":"Y Suo","year":"2023","unstructured":"Suo, Y. et al. Fc fragment of IgG binding protein is correlated with immune infiltration levels in hepatocellular carcinoma. Biomol. Biomed. 23, 605\u2013615 (2023).","journal-title":"Biomol. Biomed."},{"key":"2811_CR230","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ccell.2024.12.006","volume":"43","author":"J Gao","year":"2025","unstructured":"Gao, J. et al. Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding. Cancer Cell 43, 122\u2013143.e8 (2025).","journal-title":"Cancer Cell"},{"key":"2811_CR231","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1158\/0008-5472.CAN-22-2733","volume":"83","author":"X Huang","year":"2023","unstructured":"Huang, X. et al. A Self-Propagating c-Met-SOX2 Axis Drives Cancer-Derived IgG Signaling That Promotes Lung Cancer Cell Stemness. Cancer Res 83, 1866\u20131882 (2023).","journal-title":"Cancer Res"},{"key":"2811_CR232","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/pros.24042","volume":"80","author":"C Qin","year":"2020","unstructured":"Qin, C. et al. Cancer-driven IgG promotes the development of prostate cancer although the SOX2-CIgG pathway. Prostate 80, 1134\u20131144 (2020).","journal-title":"Prostate"},{"key":"2811_CR233","doi-asserted-by":"publisher","first-page":"1178817","DOI":"10.3389\/fimmu.2023.1178817","volume":"14","author":"M Lustig","year":"2023","unstructured":"Lustig, M. et al. Disruption of the sialic acid\/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity toward tumor cells. Front. Immunol. 14, 1178817 (2023).","journal-title":"Front. Immunol."},{"key":"2811_CR234","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.immuni.2022.11.014","volume":"56","author":"R-Q Wu","year":"2023","unstructured":"Wu, R.-Q. et al. Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma. Immunity 56, 180\u2013192.e11 (2023).","journal-title":"Immunity"},{"key":"2811_CR235","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41423-019-0327-9","volume":"17","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Cancer-derived sialylated IgG promotes tumor immune escape by binding to Siglecs on effector T cells. Cell. Mol. Immunol. 17, 1148\u20131162 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"2811_CR236","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cas.15631","volume":"114","author":"T Fan","year":"2023","unstructured":"Fan, T. et al. Sialylated IgG in epithelial cancers inhibits antitumor function of T cells via Siglec-7. Cancer Sci. 114, 370\u2013383 (2023).","journal-title":"Cancer Sci."},{"key":"2811_CR237","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cca.2020.03.041","volume":"506","author":"A Komaromy","year":"2020","unstructured":"Komaromy, A., Reider, B., Jarvas, G. & Guttman, A. Glycoprotein biomarkers and analysis in chronic obstructive pulmonary disease and lung cancer with special focus on serum immunoglobulin G. Clin. Chim. Acta 506, 204\u2013213 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"2811_CR238","doi-asserted-by":"publisher","first-page":"870458","DOI":"10.3389\/fimmu.2022.870458","volume":"13","author":"W Jia","year":"2022","unstructured":"Jia, W. et al. Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope. Front. Immunol. 13, 870458 (2022).","journal-title":"Front. Immunol."},{"key":"2811_CR239","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1002\/cam4.5227","volume":"12","author":"T Zhang","year":"2023","unstructured":"Zhang, T. et al. Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma. Cancer Med 12, 3068\u20133078 (2023).","journal-title":"Cancer Med"},{"key":"2811_CR240","doi-asserted-by":"publisher","first-page":"1423775","DOI":"10.3389\/fimmu.2024.1423775","volume":"15","author":"S Xin","year":"2024","unstructured":"Xin, S., Wen, S., He, P., Zhao, Y. & Zhao, H. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer. Front. Immunol. 15, 1423775 (2024).","journal-title":"Front. Immunol."},{"key":"2811_CR241","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1634\/theoncologist.2017-0029","volume":"22","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Distinct tertiary lymphoid structure associations and their prognostic relevance in HER2 positive and negative breast cancers. Oncologist 22, 1316\u20131324 (2017).","journal-title":"Oncologist"},{"key":"2811_CR242","doi-asserted-by":"publisher","first-page":"e009243","DOI":"10.1136\/jitc-2024-009243","volume":"12","author":"TS Groen-van Schooten","year":"2024","unstructured":"Groen-van Schooten, T. S. et al. Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer. J. Immunother. Cancer 12, e009243 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR243","doi-asserted-by":"publisher","first-page":"1180209","DOI":"10.3389\/fimmu.2023.1180209","volume":"14","author":"FB Gunnarsdottir","year":"2023","unstructured":"Gunnarsdottir, F. B. et al. Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells. Front. Immunol. 14, 1180209 (2023).","journal-title":"Front. Immunol."},{"key":"2811_CR244","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59341-w","volume":"16","author":"H Li","year":"2025","unstructured":"Li, H. et al. Mature tertiary lymphoid structures evoke intratumoral T and B-cell responses via progenitor exhausted CD4+ T cells in head and neck cancer. Nat. Commun. 16, 4228 (2025).","journal-title":"Nat. Commun."},{"key":"2811_CR245","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-981-15-3532-1_2","volume":"1254","author":"S Tanaka","year":"2020","unstructured":"Tanaka, S. & Baba, Y. B-cell receptor signaling. Adv. Exp. Med. Biol. 1254, 23\u201336 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2811_CR246","doi-asserted-by":"publisher","first-page":"155284","DOI":"10.1016\/j.prp.2024.155284","volume":"257","author":"RO Saleh","year":"2024","unstructured":"Saleh, R. O. et al. Exploring the detailed role of interleukins in cancer: A comprehensive review of literature. Pathol. Res. Pract. 257, 155284 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"2811_CR247","doi-asserted-by":"publisher","first-page":"101448","DOI":"10.1016\/j.xcrm.2024.101448","volume":"5","author":"W Liu","year":"2024","unstructured":"Liu, W. et al. An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure. Cell Rep. Med. 5, 101448 (2024).","journal-title":"Cell Rep. Med."},{"key":"2811_CR248","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41423-023-01060-7","volume":"20","author":"E Playoust","year":"2023","unstructured":"Playoust, E., Remark, R., Vivier, E. & Milpied, P. Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers. Cell. Mol. Immunol. 20, 1040\u20131050 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"2811_CR249","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2174\/0118715206321574240821112747","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Immunomodulatory Roles of IL-15 in Immune Cells and its Potential for Cancer Immunotherapy. Anticancer Agents Med. Chem. 24, 1457\u20131466 (2024).","journal-title":"Anticancer Agents Med. Chem."},{"key":"2811_CR250","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41590-024-01858-1","volume":"25","author":"RA Elsner","year":"2024","unstructured":"Elsner, R. A., Smita, S. & Shlomchik, M. J. IL-12 induces a B-cell-intrinsic IL-12\/IFN\u03b3 feed-forward loop promoting extrafollicular B-cell responses. Nat. Immunol. 25, 1283\u20131295 (2024).","journal-title":"Nat. Immunol."},{"key":"2811_CR251","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44382-w","volume":"15","author":"SE McGettigan","year":"2024","unstructured":"McGettigan, S. E. et al. Secreted IgM modulates IL-10 expression in B cells. Nat. Commun. 15, 324 (2024).","journal-title":"Nat. Commun."},{"key":"2811_CR252","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.4049\/jimmunol.2100339","volume":"207","author":"JL Barnas","year":"2021","unstructured":"Barnas, J. L. et al. B-cell activation and plasma cell differentiation are promoted by IFN-\u03bb in systemic lupus erythematosus. J. Immunol. 207, 2660\u20132672 (2021).","journal-title":"J. Immunol."},{"key":"2811_CR253","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.immuni.2022.11.002","volume":"55","author":"A Frede","year":"2022","unstructured":"Frede, A. et al. B-cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healing. Immunity 55, 2336\u20132351.e12 (2022).","journal-title":"Immunity"},{"key":"2811_CR254","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21795-z","volume":"12","author":"L Gong","year":"2021","unstructured":"Gong, L. et al. Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma. Nat. Commun. 12, 1540 (2021).","journal-title":"Nat. Commun."},{"key":"2811_CR255","doi-asserted-by":"publisher","first-page":"e010534","DOI":"10.1136\/jitc-2024-010534","volume":"12","author":"T Li","year":"2024","unstructured":"Li, T. et al. Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy. J. Immunother. Cancer 12, e010534 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR256","doi-asserted-by":"publisher","first-page":"176357","DOI":"10.1016\/j.ejphar.2024.176357","volume":"967","author":"N Song","year":"2024","unstructured":"Song, N. et al. Advance in the role of chemokines\/chemokine receptors in carcinogenesis: Focus on pancreatic cancer. Eur. J. Pharmacol. 967, 176357 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"2811_CR257","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Increased PRP19 in Hepatocyte Impedes B-Cell Function to Promote Hepatocarcinogenesis. Adv. Sci. (Weinh.) 11, e2407517 (2024).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"2811_CR258","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1158\/1078-0432.CCR-21-3215","volume":"28","author":"KRM Blenman","year":"2022","unstructured":"Blenman, K. R. M. et al. Predictive markers of response to neoadjuvant durvalumab with nab-paclitaxel and dose-dense doxorubicin\/cyclophosphamide in basal-like triple-negative breast cancer. Clin. Cancer Res. 28, 2587\u20132597 (2022).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR259","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04860-1","volume":"22","author":"H Yuan","year":"2024","unstructured":"Yuan, H. et al. Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer. J. Transl. Med. 22, 48 (2024).","journal-title":"J. Transl. Med."},{"key":"2811_CR260","doi-asserted-by":"publisher","first-page":"636870","DOI":"10.3389\/fonc.2021.636870","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. CXCL12 and CD3E as indicators for tumor microenvironment modulation in bladder cancer and their correlations with immune infiltration and molecular subtypes. Front. Oncol. 11, 636870 (2021).","journal-title":"Front. Oncol."},{"key":"2811_CR261","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05606-9","volume":"22","author":"X Cai","year":"2024","unstructured":"Cai, X. et al. Reanalysis of single cell and spatial transcriptomics data reveals B-cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis. J. Transl. Med. 22, 807 (2024).","journal-title":"J. Transl. Med."},{"key":"2811_CR262","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1002\/tox.24297","volume":"39","author":"Z Xiao","year":"2024","unstructured":"Xiao, Z. et al. Single-cell and bulk RNA-sequencing reveal SPP1 and CXCL12 as cell-to-cell communication markers to predict prognosis in lung adenocarcinoma. Environ. Toxicol. 39, 4610\u20134622 (2024).","journal-title":"Environ. Toxicol."},{"key":"2811_CR263","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1158\/1535-7163.MCT-23-0281","volume":"22","author":"X Cao","year":"2023","unstructured":"Cao, X. et al. C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration. Mol. Cancer Ther. 22, 1493\u20131502 (2023).","journal-title":"Mol. Cancer Ther."},{"key":"2811_CR264","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637\u2013650 (2011).","journal-title":"Immunity"},{"key":"2811_CR265","doi-asserted-by":"publisher","first-page":"794684","DOI":"10.3389\/fimmu.2022.794684","volume":"13","author":"S Singh","year":"2022","unstructured":"Singh, S. et al. B cells are required to generate optimal anti-melanoma immunity in response to checkpoint blockade. Front. Immunol. 13, 794684 (2022).","journal-title":"Front. Immunol."},{"key":"2811_CR266","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1158\/0008-5472.CAN-18-0981","volume":"79","author":"MA Haro","year":"2019","unstructured":"Haro, M. A., Dyevoich, A. M., Phipps, J. P. & Haas, K. M. Activation of B-1 cells promotes tumor cell killing in the peritoneal cavity. Cancer Res. 79, 159\u2013170 (2019).","journal-title":"Cancer Res."},{"key":"2811_CR267","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.yexcr.2014.10.015","volume":"331","author":"M Zhou","year":"2015","unstructured":"Zhou, M. et al. Macrophages enhance tumor-derived autophagosomes (DRibbles)-induced B cells activation by TLR4\/MyD88 and CD40\/CD40L. Exp. Cell Res. 331, 320\u2013330 (2015).","journal-title":"Exp. Cell Res."},{"key":"2811_CR268","doi-asserted-by":"publisher","first-page":"111051","DOI":"10.1016\/j.celrep.2022.111051","volume":"40","author":"C Melcher","year":"2022","unstructured":"Melcher, C. et al. B-cell-mediated regulatory mechanisms control tumor-promoting intestinal inflammation. Cell Rep. 40, 111051 (2022).","journal-title":"Cell Rep."},{"key":"2811_CR269","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1158\/1078-0432.CCR-09-0537","volume":"15","author":"EL Carpenter","year":"2009","unstructured":"Carpenter, E. L. et al. Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers. Clin. Cancer Res. 15, 4277\u20134287 (2009).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR270","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/cbf.3270","volume":"35","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Vitamin D insufficiency correlates with peripheral B10 cells in patients with pituitary tumors. Cell Biochem. Funct. 35, 254\u2013259 (2017).","journal-title":"Cell Biochem. Funct."},{"key":"2811_CR271","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41388-022-02187-z","volume":"41","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Role of fibrosarcoma-induced CD11b+ myeloid cells and tumor necrosis factor-\u03b1 in B-cell responses. Oncogene 41, 1434\u20131444 (2022).","journal-title":"Oncogene"},{"key":"2811_CR272","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1873585","volume":"10","author":"K de Jonge","year":"2021","unstructured":"de Jonge, K. et al. Inflammatory B cells correlate with failure to checkpoint blockade in melanoma patients. Oncoimmunology 10, 1873585 (2021).","journal-title":"Oncoimmunology"},{"key":"2811_CR273","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1158\/2326-6066.CIR-20-0839","volume":"9","author":"ME Shaul","year":"2021","unstructured":"Shaul, M. E. et al. Tumor-associated neutrophils drive B-cell recruitment and their differentiation to plasma cells. Cancer Immunol. Res. 9, 811\u2013824 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"2811_CR274","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136417","volume":"5","author":"M Yarchoan","year":"2020","unstructured":"Yarchoan, M. et al. Effects of B-cell-activating factor on tumor immunity. JCI Insight 5, e136417 (2020).","journal-title":"JCI Insight"},{"key":"2811_CR275","doi-asserted-by":"publisher","first-page":"837842","DOI":"10.3389\/fimmu.2022.837842","volume":"13","author":"BM Janjic","year":"2022","unstructured":"Janjic, B. M., Kulkarni, A., Ferris, R. L., Vujanovic, L. & Vujanovic, N. L. Human B cells mediate innate anti-cancer cytotoxicity through concurrent engagement of multiple TNF superfamily ligands. Front. Immunol. 13, 837842 (2022).","journal-title":"Front. Immunol."},{"key":"2811_CR276","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/978-0-387-09789-3_2","volume":"640","author":"RJ Brezski","year":"2008","unstructured":"Brezski, R. J. & Monroe, J. G. B-cell receptor. Adv. Exp. Med. Biol. 640, 12\u201321 (2008).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2811_CR277","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms25010010","volume":"25","author":"A Tkachenko","year":"2023","unstructured":"Tkachenko, A., Kupcova, K. & Havranek, O. B-cell receptor signaling and beyond: The role of Ig\u03b1 (CD79a)\/Ig\u03b2 (CD79b) in normal and malignant B cells. Int. J. Mol. Sci. 25, 10 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2811_CR278","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/ni.1900","volume":"11","author":"CC Goodnow","year":"2010","unstructured":"Goodnow, C. C., Vinuesa, C. G., Randall, K. L., Mackay, F. & Brink, R. Control systems and decision making for antibody production. Nat. Immunol. 11, 681\u2013688 (2010).","journal-title":"Nat. Immunol."},{"key":"2811_CR279","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00018-014-1806-x","volume":"72","author":"M Kremlitzka","year":"2015","unstructured":"Kremlitzka, M., M\u00e1csik-Valent, B. & Erdei, A. Syk is indispensable for CpG-induced activation and differentiation of human B cells. Cell. Mol. Life Sci. 72, 2223\u20132236 (2015).","journal-title":"Cell. Mol. Life Sci."},{"key":"2811_CR280","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/08830185.2014.885022","volume":"33","author":"M Szyd\u0142owski","year":"2014","unstructured":"Szyd\u0142owski, M., Jab\u0142o\u0144ska, E. & Juszczy\u0144ski, P. FOXO1 transcription factor: a critical effector of the PI3K-AKT axis in B-cell development. Int. Rev. Immunol. 33, 146\u2013157 (2014).","journal-title":"Int. Rev. Immunol."},{"key":"2811_CR281","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.4049\/jimmunol.1500461","volume":"194","author":"JA Ackermann","year":"2015","unstructured":"Ackermann, J. A. et al. Syk tyrosine kinase is critical for B-cell antibody responses and memory B-cell survival. J. Immunol. 194, 4650\u20134656 (2015).","journal-title":"J. Immunol."},{"key":"2811_CR282","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1182\/blood-2002-05-1525","volume":"100","author":"H Gary-Gouy","year":"2002","unstructured":"Gary-Gouy, H. et al. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 100, 4537\u20134543 (2002).","journal-title":"Blood"},{"key":"2811_CR283","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jaci.2012.03.014","volume":"129","author":"S Iwata","year":"2012","unstructured":"Iwata, S. et al. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation. J. Allergy Clin. Immunol. 129, 1594\u20131601.e2 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2811_CR284","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1769","volume":"3","author":"EJ Pone","year":"2012","unstructured":"Pone, E. J. et al. BCR-signaling synergizes with TLR-signaling for induction of AID and immunoglobulin class-switching through the noncanonical NF-\u03baB pathway. Nat. Commun. 3, 767 (2012).","journal-title":"Nat. Commun."},{"key":"2811_CR285","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02001-2","volume":"23","author":"Y Xie","year":"2024","unstructured":"Xie, Y. et al. Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells. Mol. Cancer 23, 95 (2024).","journal-title":"Mol. Cancer"},{"key":"2811_CR286","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30613-z","volume":"13","author":"S Shankar","year":"2022","unstructured":"Shankar, S. et al. Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1\/STAT3 axis. Nat. Commun. 13, 3121 (2022).","journal-title":"Nat. Commun."},{"key":"2811_CR287","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.4049\/jimmunol.1301559","volume":"191","author":"B Rodr\u00edguez-Bayona","year":"2013","unstructured":"Rodr\u00edguez-Bayona, B., Ramos-Amaya, A., L\u00f3pez-Blanco, R., Campos-Caro, A. & Brieva, J. A. STAT-3 activation by differential cytokines is critical for human in vivo-generated plasma cell survival and Ig secretion. J. Immunol. 191, 4996\u20135004 (2013).","journal-title":"J. Immunol."},{"key":"2811_CR288","doi-asserted-by":"publisher","first-page":"e1180485","DOI":"10.1080\/2162402X.2016.1180485","volume":"5","author":"M Zhou","year":"2016","unstructured":"Zhou, M. et al. Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-\u03baB signaling pathway. Oncoimmunology 5, e1180485 (2016).","journal-title":"Oncoimmunology"},{"key":"2811_CR289","doi-asserted-by":"publisher","first-page":"114176","DOI":"10.1016\/j.intimp.2025.114176","volume":"148","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Exosomes derived from colorectal cancer cells suppress B-cell mediated anti-tumor immunity. Int. Immunopharmacol. 148, 114176 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR290","doi-asserted-by":"publisher","first-page":"1176994","DOI":"10.3389\/fimmu.2023.1176994","volume":"14","author":"L Ding","year":"2023","unstructured":"Ding, L. et al. Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors. Front. Immunol. 14, 1176994 (2023).","journal-title":"Front. Immunol."},{"key":"2811_CR291","doi-asserted-by":"publisher","first-page":"106999","DOI":"10.1016\/j.oraloncology.2024.106999","volume":"158","author":"Y Ge","year":"2024","unstructured":"Ge, Y. et al. Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment. Oral. Oncol. 158, 106999 (2024).","journal-title":"Oral. Oncol."},{"key":"2811_CR292","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/1440-1681.13317","volume":"47","author":"D-N Tong","year":"2020","unstructured":"Tong, D.-N. et al. Characterization of B-cell-mediated PD-1\/PD-L1 interaction in pancreatic cancer patients. Clin. Exp. Pharmacol. Physiol. 47, 1342\u20131349 (2020).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2811_CR293","doi-asserted-by":"publisher","first-page":"111295","DOI":"10.1016\/j.celrep.2022.111295","volume":"40","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers. Cell Rep. 40, 111295 (2022).","journal-title":"Cell Rep."},{"key":"2811_CR294","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow, M. A., Sidlow, R. & Hellmann, M. D. Immune-related adverse events associated with immune checkpoint blockade. N. Engl. J. Med. 378, 158\u2013168 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2811_CR295","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1634\/theoncologist.2019-IO-S1-s05","volume":"24","author":"L Xia","year":"2019","unstructured":"Xia, L., Liu, Y. & Wang, Y. PD-1\/PD-L1 blockade therapy in advanced non-small cell lung cancer: Current status and future directions. Oncologist 24, S31\u2013S41 (2019).","journal-title":"Oncologist"},{"key":"2811_CR296","doi-asserted-by":"publisher","first-page":"e1075112","DOI":"10.1080\/2162402X.2015.1075112","volume":"5","author":"H Guan","year":"2016","unstructured":"Guan, H. et al. PD-L1 mediated the differentiation of tumor-infiltrating CD19+ B lymphocytes and T cells in Invasive breast cancer. Oncoimmunology 5, e1075112 (2016).","journal-title":"Oncoimmunology"},{"key":"2811_CR297","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1111\/cas.13836","volume":"109","author":"L Qiu","year":"2018","unstructured":"Qiu, L. et al. Functionally impaired follicular helper T cells induce regulatory B cells and CD14+ human leukocyte antigen-DR- cell differentiation in non-small cell lung cancer. Cancer Sci. 109, 3751\u20133761 (2018).","journal-title":"Cancer Sci."},{"key":"2811_CR298","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/intimm\/dxw007","volume":"28","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Mammary-tumor-educated B cells acquire LAP\/TGF-\u03b2 and PD-L1 expression and suppress anti-tumor immune responses. Int. Immunol. 28, 423\u2013433 (2016).","journal-title":"Int. Immunol."},{"key":"2811_CR299","doi-asserted-by":"publisher","first-page":"879398","DOI":"10.3389\/fonc.2022.879398","volume":"12","author":"J-C Guo","year":"2022","unstructured":"Guo, J.-C. et al. B cells in tumor microenvironment associated with the clinical benefit to programmed cell death protein-1 blockade therapy in patients with advanced esophageal squamous cell carcinoma. Front. Oncol. 12, 879398 (2022).","journal-title":"Front. Oncol."},{"key":"2811_CR300","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour, S. et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521, 94\u201398 (2015).","journal-title":"Nature"},{"key":"2811_CR301","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s40425-019-0744-4","volume":"7","author":"Y-L Chen","year":"2019","unstructured":"Chen, Y.-L. et al. BTLA blockade enhances Cancer therapy by inhibiting IL-6\/IL-10-induced CD19high B lymphocytes. J. Immunother. Cancer 7, 313 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR302","doi-asserted-by":"publisher","first-page":"e006694","DOI":"10.1136\/jitc-2023-006694","volume":"11","author":"W-Z Sun","year":"2023","unstructured":"Sun, W.-Z. et al. Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors. J. Immunother. Cancer 11, e006694 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR303","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1158\/1078-0432.CCR-23-1759","volume":"29","author":"H Huang","year":"2023","unstructured":"Huang, H. et al. CD24hiCD27+ Bregs within metastatic lymph nodes promote multidrug resistance in breast cancer. Clin. Cancer Res. 29, 5227\u20135243 (2023).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR304","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02960-1","volume":"21","author":"Z-A Xia","year":"2023","unstructured":"Xia, Z.-A. et al. The expression profiles of signature genes from CD103+LAG3+ tumor-infiltrating lymphocyte subsets predict breast cancer survival. BMC Med 21, 268 (2023).","journal-title":"BMC Med"},{"key":"2811_CR305","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105098","volume":"103","author":"H Zhu","year":"2024","unstructured":"Zhu, H. et al. Intratumoral CD38+CD19+B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinoma. EBioMedicine 103, 105098 (2024).","journal-title":"EBioMedicine"},{"key":"2811_CR306","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.intimp.2017.05.018","volume":"49","author":"H Mao","year":"2017","unstructured":"Mao, H. et al. Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T-cell inflammation. Int. Immunopharmacol. 49, 95\u2013101 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR307","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4049\/jimmunol.1602107","volume":"199","author":"Q Ding","year":"2017","unstructured":"Ding, Q., Mohib, K., Kuchroo, V. K. & Rothstein, D. M. TIM-4 Identifies IFN-\u03b3-Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft Rejection. J. Immunol. 199, 2585\u20132595 (2017).","journal-title":"J. Immunol."},{"key":"2811_CR308","doi-asserted-by":"publisher","first-page":"108735","DOI":"10.1016\/j.intimp.2022.108735","volume":"108","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Peritumoral TIGIT+CD20+ B-cell infiltration indicates poor prognosis but favorable adjuvant chemotherapeutic response in gastric cancer. Int. Immunopharmacol. 108, 108735 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR309","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1182\/blood-2014-03-563940","volume":"124","author":"C Lee-Chang","year":"2014","unstructured":"Lee-Chang, C. et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood 124, 1450\u20131459 (2014).","journal-title":"Blood"},{"key":"2811_CR310","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.4049\/jimmunol.1502034","volume":"196","author":"C Lee-Chang","year":"2016","unstructured":"Lee-Chang, C. et al. Aging converts innate B1a cells into potent CD8+ T-cell inducers. J. Immunol. 196, 3385\u20133397 (2016).","journal-title":"J. Immunol."},{"key":"2811_CR311","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1158\/0008-5472.CAN-12-4174","volume":"73","author":"BD Curti","year":"2013","unstructured":"Curti, B. D. et al. OX40 is a potent immune-stimulating target in late-stage cancer patients. Cancer Res 73, 7189\u20137198 (2013).","journal-title":"Cancer Res"},{"key":"2811_CR312","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1089\/dna.2017.3814","volume":"36","author":"H Mao","year":"2017","unstructured":"Mao, H. et al. CD19loCD27hi plasmablasts suppress harmful Th17 inflammation through interleukin 10 pathway in colorectal cancer. DNA Cell Biol. 36, 870\u2013877 (2017).","journal-title":"DNA Cell Biol."},{"key":"2811_CR313","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/CJI.0000000000000246","volume":"41","author":"C Merz","year":"2018","unstructured":"Merz, C. et al. The Hexavalent CD40 Agonist HERA-CD40L Induces T-cell-mediated antitumor immune response through activation of antigen-presenting cells. J. Immunother. 41, 385\u2013398 (2018).","journal-title":"J. Immunother."},{"key":"2811_CR314","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1181","volume":"13","author":"S Nakamura","year":"2023","unstructured":"Nakamura, S. et al. Single-cell transcriptome analysis reveals functional changes in tumor-infiltrating B lymphocytes after chemotherapy in esophageal squamous cell carcinoma. Clin. Transl. Med. 13, e1181 (2023).","journal-title":"Clin. Transl. Med."},{"key":"2811_CR315","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.smim.2009.06.002","volume":"21","author":"K Dugger","year":"2009","unstructured":"Dugger, K., Lowder, T. W., Tucker, T. A. & Schwiebert, L. M. Epithelial cells as immune effector cells: The role of CD40. Semin. Immunol. 21, 289\u2013292 (2009).","journal-title":"Semin. Immunol."},{"key":"2811_CR316","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/ijc.34438","volume":"152","author":"A Jo","year":"2023","unstructured":"Jo, A. et al. CTLA-4 inhibition facilitates follicular T and B-cell interaction and the production of tumor-specific antibodies. Int. J. Cancer 152, 1964\u20131976 (2023).","journal-title":"Int. J. Cancer"},{"key":"2811_CR317","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/CJI.0b013e3181ee6ba9","volume":"33","author":"P Zhou","year":"2010","unstructured":"Zhou, P. et al. Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody. J. Immunother. 33, 789\u2013797 (2010).","journal-title":"J. Immunother."},{"key":"2811_CR318","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.4049\/jimmunol.1403076","volume":"195","author":"YH Kim","year":"2015","unstructured":"Kim, Y. H. et al. Authentic GITR signaling fails to induce tumor regression unless Foxp3+ regulatory T cells are depleted. J. Immunol. 195, 4721\u20134729 (2015).","journal-title":"J. Immunol."},{"key":"2811_CR319","doi-asserted-by":"publisher","first-page":"113002","DOI":"10.1016\/j.intimp.2024.113002","volume":"141","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. CD19+CD73+ B cells infiltration indicates poor prognosis and unfavorable responses to immunotherapy in gastric cancer. Int. Immunopharmacol. 141, 113002 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR320","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.3390\/ijms23095163","volume":"23","author":"FJ Hansen","year":"2022","unstructured":"Hansen, F. J. et al. Tumor Infiltration with CD20+CD73+ B cells correlates with better outcome in colorectal cancer. Int. J. Mol. Sci. 23, 5163 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2811_CR321","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/ijc.30169","volume":"139","author":"A Tang","year":"2016","unstructured":"Tang, A. et al. B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer. Int. J. Cancer 139, 1358\u20131371 (2016).","journal-title":"Int. J. Cancer"},{"key":"2811_CR322","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.euros.2021.05.002","volume":"29","author":"S Chenard","year":"2021","unstructured":"Chenard, S. et al. Sexual dimorphism in outcomes of non-muscle-invasive bladder cancer: A role of CD163+ macrophages, B cells, and PD-L1 immune checkpoint. Eur. Urol. Open Sci. 29, 50\u201358 (2021).","journal-title":"Eur. Urol. Open Sci."},{"key":"2811_CR323","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-023-01499-1","volume":"16","author":"L Cai","year":"2023","unstructured":"Cai, L., Li, Y., Tan, J., Xu, L. & Li, Y. Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. J. Hematol. Oncol. 16, 101 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"2811_CR324","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s00432-024-05803-5","volume":"150","author":"Z Lin","year":"2024","unstructured":"Lin, Z., Xiao, S., Qi, Y., Guo, J. & Lu, L. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib. J. Cancer Res. Clin. Oncol. 150, 262 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2811_CR325","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-12-3450","volume":"73","author":"S Lindner","year":"2013","unstructured":"Lindner, S. et al. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res 73, 2468\u20132479 (2013).","journal-title":"Cancer Res"},{"key":"2811_CR326","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.molimm.2020.10.001","volume":"128","author":"N Hl","year":"2020","unstructured":"Hl, N. et al. Notch signaling induces a transcriptionally permissive state at the Complement C3d Receptor 2 (CR2) promoter in a pre-B-cell model. Mol. Immunol. 128, 150\u2013164 (2020).","journal-title":"Mol. Immunol."},{"key":"2811_CR327","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1182\/blood.2021012428","volume":"138","author":"R Dowery","year":"2021","unstructured":"Dowery, R. et al. Peripheral B cells repress B-cell regeneration in aging through a TNF-\u03b1\/IGFBP-1\/IGF-1 immune-endocrine axis. Blood 138, 1817\u20131829 (2021).","journal-title":"Blood"},{"key":"2811_CR328","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41590-021-00926-0","volume":"22","author":"A Cumpelik","year":"2021","unstructured":"Cumpelik, A. et al. Dynamic regulation of B-cell complement signaling is integral to germinal center responses. Nat. Immunol. 22, 757\u2013768 (2021).","journal-title":"Nat. Immunol."},{"key":"2811_CR329","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12929-023-00964-w","volume":"30","author":"N Hm","year":"2023","unstructured":"Hm, N., Cc, C., Ch, L., Mmm, A. & Hd, W. Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments. J. Biomed. Sci. 30, 69 (2023).","journal-title":"J. Biomed. Sci."},{"key":"2811_CR330","doi-asserted-by":"publisher","first-page":"e12588","DOI":"10.7717\/peerj.12588","volume":"10","author":"H Song","year":"2022","unstructured":"Song, H., Huang, X.-F., Hu, S.-Y., Lu, L.-L. & Yang, X.-Y. The LINC00261\/MiR105-5p\/SELL axis is involved in dysfunction of B-cell and is associated with overall survival in hepatocellular carcinoma. PeerJ 10, e12588 (2022).","journal-title":"PeerJ"},{"key":"2811_CR331","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/cmi.2014.129","volume":"12","author":"M Bp","year":"2015","unstructured":"Bp, M. et al. Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cells. Cell. Mol. Immunol. 12, 750\u2013756 (2015).","journal-title":"Cell. Mol. Immunol."},{"key":"2811_CR332","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1084\/jem.20150489","volume":"212","author":"A Mehta","year":"2015","unstructured":"Mehta, A. et al. The microRNA-212\/132 cluster regulates B-cell development by targeting Sox4. J. Exp. Med. 212, 1679\u20131692 (2015).","journal-title":"J. Exp. Med."},{"key":"2811_CR333","doi-asserted-by":"publisher","first-page":"9653","DOI":"10.3748\/wjg.v20.i29.9653","volume":"20","author":"ER Mann","year":"2014","unstructured":"Mann, E. R. & Li, X. Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B cells. World J. Gastroenterol. 20, 9653\u20139664 (2014).","journal-title":"World J. Gastroenterol."},{"key":"2811_CR334","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.humimm.2019.05.011","volume":"80","author":"M Hong","year":"2019","unstructured":"Hong, M. et al. Immunomodulation of human CD19+CD25high regulatory B cells via Th17\/Foxp3 regulatory T cells and Th1\/Th2 cytokines. Hum. Immunol. 80, 863\u2013870 (2019).","journal-title":"Hum. Immunol."},{"key":"2811_CR335","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00262-018-2250-9","volume":"68","author":"Q Jiang","year":"2019","unstructured":"Jiang, Q. et al. CD19+ tumor-infiltrating B cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer. Cancer Immunol. Immunother. 68, 45\u201356 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"2811_CR336","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2355-x","volume":"11","author":"S Li","year":"2020","unstructured":"Li, S. et al. Tumor-educated B cells promote renal cancer metastasis by inducing the IL-1\u03b2\/HIF-2\u03b1\/Notch1 signals. Cell Death Dis. 11, 163 (2020).","journal-title":"Cell Death Dis."},{"key":"2811_CR337","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/hep.32444","volume":"76","author":"Y He","year":"2022","unstructured":"He, Y. et al. Single-cell profiling of human CD127+ innate lymphoid cells reveals diverse immune phenotypes in hepatocellular carcinoma. Hepatology 76, 1013\u20131029 (2022).","journal-title":"Hepatology"},{"key":"2811_CR338","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.intimp.2018.10.045","volume":"66","author":"M Zhang","year":"2019","unstructured":"Zhang, M. et al. PD-1 blockade augments humoral immunity through ICOS-mediated CD4+ T-cell instruction. Int. Immunopharmacol. 66, 127\u2013138 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR339","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.trsl.2024.11.002","volume":"275","author":"Q-F Huang","year":"2025","unstructured":"Huang, Q.-F. et al. Lympho-myeloid aggregate-infiltrating CD20+ B cells display a double-negative phenotype and correlate with poor prognosis in esophageal squamous cell carcinoma. Transl. Res. 275, 48\u201361 (2025).","journal-title":"Transl. Res."},{"key":"2811_CR340","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.730","volume":"12","author":"H Jiang","year":"2022","unstructured":"Jiang, H. et al. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing. Clin. Transl. Med. 12, e730 (2022).","journal-title":"Clin. Transl. Med."},{"key":"2811_CR341","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52153-4","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumor progression and immunotherapy response in nasopharyngeal carcinoma. Nat. Commun. 15, 7713 (2024).","journal-title":"Nat. Commun."},{"key":"2811_CR342","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1038\/s41388-022-02425-4","volume":"41","author":"B Diskin","year":"2022","unstructured":"Diskin, B. et al. BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Oncogene 41, 4349\u20134360 (2022).","journal-title":"Oncogene"},{"key":"2811_CR343","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/gutjnl-2015-310814","volume":"66","author":"M Garnelo","year":"2017","unstructured":"Garnelo, M. et al. Interaction between tumor-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut 66, 342\u2013351 (2017).","journal-title":"Gut"},{"key":"2811_CR344","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1053\/j.gastro.2019.01.250","volume":"156","author":"Y Wei","year":"2019","unstructured":"Wei, Y. et al. Plasma cell polarization to the immunoglobulin G phenotype in hepatocellular carcinomas involves epigenetic alterations and promotes hepatoma progression in mice. Gastroenterology 156, 1890\u20131904.e16 (2019).","journal-title":"Gastroenterology"},{"key":"2811_CR345","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12026-020-09120-0","volume":"68","author":"Q-Y Ma","year":"2020","unstructured":"Ma, Q.-Y., Chen, J. & Zhao, J. Follicular cytotoxic CD8 T cells present high cytokine expression, and are more susceptible to Breg-mediated suppression in non-small cell lung cancer. Immunol. Res. 68, 54\u201362 (2020).","journal-title":"Immunol. Res."},{"key":"2811_CR346","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","volume":"166","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. Tertiary lymphoid structure-associated B cells enhance CXCL13+CD103+CD8+ tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy. Gastroenterology 166, 1069\u20131084 (2024).","journal-title":"Gastroenterology"},{"key":"2811_CR347","doi-asserted-by":"publisher","first-page":"111652","DOI":"10.1016\/j.yexcr.2019.111652","volume":"384","author":"H-T Hu","year":"2019","unstructured":"Hu, H.-T., Ai, X., Lu, M., Song, Z. & Li, H. Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer. Exp. Cell Res. 384, 111652 (2019).","journal-title":"Exp. Cell Res."},{"key":"2811_CR348","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.yexcr.2019.01.021","volume":"376","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation. Exp. Cell Res. 376, 192\u2013197 (2019).","journal-title":"Exp. Cell Res."},{"key":"2811_CR349","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795 (2013).","journal-title":"Immunity"},{"key":"2811_CR350","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2326-6066.CIR-19-0349","volume":"8","author":"B Mirlekar","year":"2020","unstructured":"Mirlekar, B. et al. B-cell-derived IL35 Drives STAT3-dependent CD8+ T-cell exclusion in pancreatic cancer. Cancer Immunol. Res. 8, 292\u2013308 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"2811_CR351","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.253","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer. Clin. Transl. Med. 11, e253 (2021).","journal-title":"Clin. Transl. Med."},{"key":"2811_CR352","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350615","volume":"54","author":"F Bekkat","year":"2024","unstructured":"Bekkat, F. et al. Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties. Eur. J. Immunol. 54, e2350615 (2024).","journal-title":"Eur. J. Immunol."},{"key":"2811_CR353","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07195-3","volume":"15","author":"G Fan","year":"2024","unstructured":"Fan, G. et al. DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma. Cell Death Dis. 15, 797 (2024).","journal-title":"Cell Death Dis."},{"key":"2811_CR354","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12865-017-0216-x","volume":"18","author":"W Mou","year":"2017","unstructured":"Mou, W. et al. \u03b3\u03b4TFH cells promote B-cell maturation and antibody production in neuroblastoma. BMC Immunol. 18, 36 (2017).","journal-title":"BMC Immunol."},{"key":"2811_CR355","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00262-024-03887-z","volume":"74","author":"F Wei","year":"2024","unstructured":"Wei, F. et al. Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer. Cancer Immunol. Immunother. 74, 36 (2024).","journal-title":"Cancer Immunol. Immunother."},{"key":"2811_CR356","doi-asserted-by":"publisher","first-page":"109422","DOI":"10.1016\/j.celrep.2021.109422","volume":"36","author":"AB Rodriguez","year":"2021","unstructured":"Rodriguez, A. B. et al. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep. 36, 109422 (2021).","journal-title":"Cell Rep."},{"key":"2811_CR357","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4049\/jimmunol.1701069","volume":"201","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Myeloid-derived suppressor cells impair B-cell responses in lung cancer through IL-7 and STAT5. J. Immunol. 201, 278\u2013295 (2018).","journal-title":"J. Immunol."},{"key":"2811_CR358","doi-asserted-by":"publisher","first-page":"104788","DOI":"10.1016\/j.cellimm.2023.104788","volume":"395\u2013396","author":"J Maslanka","year":"2024","unstructured":"Maslanka, J. et al. Loss of B1 and marginal zone B cells during ovarian cancer. Cell. Immunol. 395\u2013396, 104788 (2024).","journal-title":"Cell. Immunol."},{"key":"2811_CR359","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.immuni.2008.04.007","volume":"28","author":"NE Harwood","year":"2008","unstructured":"Harwood, N. E. & Batista, F. D. New insights into the early molecular events underlying B-cell activation. Immunity 28, 609\u2013619 (2008).","journal-title":"Immunity"},{"key":"2811_CR360","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-immunol-030409-101216","volume":"28","author":"NE Harwood","year":"2010","unstructured":"Harwood, N. E. & Batista, F. D. Early events in B-cell activation. Annu. Rev. Immunol. 28, 185\u2013210 (2010).","journal-title":"Annu. Rev. Immunol."},{"key":"2811_CR361","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/imr.13016","volume":"303","author":"MP Cancro","year":"2021","unstructured":"Cancro, M. P. & Tomayko, M. M. Memory B cells and plasma cells: The differentiative continuum of humoral immunity. Immunol. Rev. 303, 72\u201382 (2021).","journal-title":"Immunol. Rev."},{"key":"2811_CR362","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221105","volume":"220","author":"SG Tangye","year":"2023","unstructured":"Tangye, S. G., Nguyen, T., Deenick, E. K., Bryant, V. L. & Ma, C. S. Inborn errors of human B-cell development, differentiation, and function. J. Exp. Med. 220, e20221105 (2023).","journal-title":"J. Exp. Med."},{"key":"2811_CR363","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1146\/annurev.immunol.21.120601.141138","volume":"21","author":"KL Calame","year":"2003","unstructured":"Calame, K. L., Lin, K.-I. & Tunyaplin, C. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21, 205\u2013230 (2003).","journal-title":"Annu. Rev. Immunol."},{"key":"2811_CR364","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/ajt.13087","volume":"15","author":"MY Yeung","year":"2015","unstructured":"Yeung, M. Y. et al. TIM-1 signaling is required for maintenance and induction of regulatory B cells. Am. J. Transplant. 15, 942\u2013953 (2015).","journal-title":"Am. J. Transplant."},{"key":"2811_CR365","doi-asserted-by":"publisher","first-page":"10619","DOI":"10.7150\/thno.44871","volume":"10","author":"QF Zhang","year":"2020","unstructured":"Zhang, Q. F. et al. CDK4\/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B-cell-dependent manner. Theranostics 10, 10619\u201310633 (2020).","journal-title":"Theranostics"},{"key":"2811_CR366","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/jclinpath-2021-207517","volume":"74","author":"MP Lythgoe","year":"2021","unstructured":"Lythgoe, M. P., Liu, D. S. K., Annels, N. E., Krell, J. & Frampton, A. E. Gene of the month: lymphocyte-activation gene 3 (LAG-3). J. Clin. Pathol. 74, 543\u2013547 (2021).","journal-title":"J. Clin. Pathol."},{"key":"2811_CR367","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/s41590-023-01540-y","volume":"24","author":"R Sharma","year":"2023","unstructured":"Sharma, R. et al. Distinct metabolic requirements regulate B-cell activation and germinal center responses. Nat. Immunol. 24, 1358\u20131369 (2023).","journal-title":"Nat. Immunol."},{"key":"2811_CR368","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41577-025-01137-6","volume":"25","author":"A Samiea","year":"2025","unstructured":"Samiea, A., Celis, G., Yadav, R., Rodda, L. B. & Moreau, J. M. B cells in nonlymphoid tissues. Nat. Rev. Immunol. 25, 483\u2013496 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"2811_CR369","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"RX Wang","year":"2014","unstructured":"Wang, R. X. et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 20, 633\u2013641 (2014).","journal-title":"Nat. Med."},{"key":"2811_CR370","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/imr.12741","volume":"288","author":"SA Jenks","year":"2019","unstructured":"Jenks, S. A., Cashman, K. S., Woodruff, M. C., Lee, F. E.-H. & Sanz, I. Extrafollicular responses in humans and SLE. Immunol. Rev. 288, 136\u2013148 (2019).","journal-title":"Immunol. Rev."},{"key":"2811_CR371","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri2217","volume":"8","author":"U Klein","year":"2008","unstructured":"Klein, U. & Dalla-Favera, R. Germinal centers: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 8, 22\u201333 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"2811_CR372","doi-asserted-by":"publisher","first-page":"10968","DOI":"10.3390\/ijms252010968","volume":"25","author":"C Liongue","year":"2024","unstructured":"Liongue, C., Almohaisen, L. J. F. & Ward, C. A. B-Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond. Int. J. Mol. Sci. 25, 10968 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"2811_CR373","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41392-021-00725-x","volume":"6","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct. Target Ther. 6, 341 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"2811_CR374","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh, R., Letai, A. & Sarosiek, K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 20, 175\u2013193 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2811_CR375","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/cei.13522","volume":"203","author":"PML Del","year":"2021","unstructured":"Del, P. M. L. et al. Defective Bcl-2 expression in memory B cells from common variable immunodeficiency patients. Clin. Exp. Immunol. 203, 341\u2013350 (2021).","journal-title":"Clin. Exp. Immunol."},{"key":"2811_CR376","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1191-8","volume":"9","author":"A L\u00f3pez-G\u00f3mez","year":"2018","unstructured":"L\u00f3pez-G\u00f3mez, A., Clemente, A., Cunill, V., Pons, J. & Ferrer, M. J. IL-21 and anti-CD40 restore Bcl-2 family protein imbalance in vitro in low-survival CD27+ B cells from CVID patients. Cell Death Dis. 9, 1156 (2018).","journal-title":"Cell Death Dis."},{"key":"2811_CR377","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.3390\/ijms231710095","volume":"23","author":"NP Nasrabadi","year":"2022","unstructured":"Nasrabadi, N. P., Martin, D., Gharib, E. & Robichaud, G. A. The pleiotropy of PAX5 gene products and function. Int. J. Mol. Sci. 23, 10095 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2811_CR378","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41423-024-01213-2","volume":"21","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Rack1 regulates B-cell development and function by binding to and stabilizing the transcription factor Pax5. Cell. Mol. Immunol. 21, 1282\u20131295 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"2811_CR379","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.celrep.2019.10.097","volume":"29","author":"YSM Low","year":"2019","unstructured":"Low, Y. S. M. et al. IRF4 activity is required in established plasma cells to regulate gene transcription and mitochondrial homeostasis. Cell Rep. 29, 2634\u20132645.e5 (2019).","journal-title":"Cell Rep."},{"key":"2811_CR380","doi-asserted-by":"publisher","first-page":"e2109548118","DOI":"10.1073\/pnas.2109548118","volume":"118","author":"KJ Choi","year":"2021","unstructured":"Choi, K. J. et al. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases. Proc. Natl. Acad. Sci. USA 118, e2109548118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2811_CR381","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2183\/pjab.94.017","volume":"94","author":"T Mino","year":"2018","unstructured":"Mino, T. & Takeuchi, O. Posttranscriptional regulation of immune responses by RNA binding proteins. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 94, 248\u2013258 (2018).","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"2811_CR382","doi-asserted-by":"publisher","first-page":"e2250226","DOI":"10.1002\/eji.202250226","volume":"53","author":"B Zhou","year":"2023","unstructured":"Zhou, B. et al. Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression. Eur. J. Immunol. 53, e2250226 (2023).","journal-title":"Eur. J. Immunol."},{"key":"2811_CR383","doi-asserted-by":"publisher","first-page":"105003","DOI":"10.1016\/j.ebiom.2024.105003","volume":"101","author":"DF Modugno","year":"2024","unstructured":"Modugno, D. F. et al. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer. EBioMedicine 101, 105003 (2024).","journal-title":"EBioMedicine"},{"key":"2811_CR384","doi-asserted-by":"publisher","first-page":"217045","DOI":"10.1016\/j.canlet.2024.217045","volume":"597","author":"Y Yin","year":"2024","unstructured":"Yin, Y. et al. Overactivation of XBP1 in plasma cells implies worse survival through innate immunity in esophageal squamous cell carcinoma. Cancer Lett. 597, 217045 (2024).","journal-title":"Cancer Lett."},{"key":"2811_CR385","doi-asserted-by":"publisher","first-page":"e11697","DOI":"10.7717\/peerj.11697","volume":"9","author":"F Jiang","year":"2021","unstructured":"Jiang, F., Liang, M., Huang, X., Shi, W. & Wang, Y. High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma. PeerJ 9, e11697 (2021).","journal-title":"PeerJ"},{"key":"2811_CR386","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/imr.12733","volume":"288","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. & Good-Jacobson, K. L. Epigenetic regulation of B-cell fate and function during an immune response. Immunol. Rev. 288, 75\u201384 (2019).","journal-title":"Immunol. Rev."},{"key":"2811_CR387","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ijc.35229","volume":"156","author":"S Muraoka","year":"2025","unstructured":"Muraoka, S. et al. Tumor-derived lactic acid promotes acetylation of histone H3K27 and differentiation of IL-10-producing regulatory B cells through direct and indirect signaling pathways. Int. J. Cancer 156, 840\u2013852 (2025).","journal-title":"Int. J. Cancer"},{"key":"2811_CR388","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/hep.32442","volume":"77","author":"Z Lu","year":"2023","unstructured":"Lu, Z. et al. Ten-eleven translocation-2 inactivation restrains IL-10-producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma. Hepatology 77, 745\u2013759 (2023).","journal-title":"Hepatology"},{"key":"2811_CR389","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1074\/jbc.M116.713842","volume":"291","author":"H Tanaka","year":"2016","unstructured":"Tanaka, H. et al. Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3. J. Biol. Chem. 291, 6316\u20136330 (2016).","journal-title":"J. Biol. Chem."},{"key":"2811_CR390","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/onc.2013.535","volume":"34","author":"A Batlle-L\u00f3pez","year":"2015","unstructured":"Batlle-L\u00f3pez, A. et al. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus. Oncogene 34, 246\u2013256 (2015).","journal-title":"Oncogene"},{"key":"2811_CR391","doi-asserted-by":"publisher","first-page":"1369626","DOI":"10.3389\/fimmu.2024.1369626","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Wu, Y., Yan, G. & Zhang, G. Tertiary lymphoid structures in cancer: maturation and induction. Front. Immunol. 15, 1369626 (2024).","journal-title":"Front. Immunol."},{"key":"2811_CR392","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s43018-021-00234-4","volume":"2","author":"WJ Ho","year":"2021","unstructured":"Ho, W. J. et al. Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor Immunity. Nat. Cancer 2, 891\u2013903 (2021).","journal-title":"Nat. Cancer"},{"key":"2811_CR393","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/jclinpath-2015-203089","volume":"69","author":"HJ Lee","year":"2016","unstructured":"Lee, H. J. et al. Tertiary lymphoid structures: prognostic significance and relationship with tumor-infiltrating lymphocytes in triple-negative breast cancer. J. Clin. Pathol. 69, 422\u2013430 (2016).","journal-title":"J. Clin. Pathol."},{"key":"2811_CR394","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/imr.12405","volume":"271","author":"M-C Dieu-Nosjean","year":"2016","unstructured":"Dieu-Nosjean, M.-C. et al. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol. Rev. 271, 260\u2013275 (2016).","journal-title":"Immunol. Rev."},{"key":"2811_CR395","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","volume":"19","author":"WH Fridman","year":"2022","unstructured":"Fridman, W. H. et al. B cells and tertiary lymphoid structures as determinants of tumor immune contexture and clinical outcome. Nat. Rev. Clin. Oncol. 19, 441\u2013457 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2811_CR396","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1084\/jem.20131737","volume":"211","author":"H Fleige","year":"2014","unstructured":"Fleige, H. et al. IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J. Exp. Med. 211, 643\u2013651 (2014).","journal-title":"J. Exp. Med."},{"key":"2811_CR397","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1016\/j.apsb.2024.05.009","volume":"14","author":"B Niu","year":"2024","unstructured":"Niu, B. et al. CCL9\/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-\u03b2. Acta Pharm. Sin. B 14, 3711\u20133729 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"2811_CR398","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ar.20902","volume":"292","author":"A Turhan","year":"2009","unstructured":"Turhan, A. et al. Vascular microarchitecture of murine colitis-associated lymphoid angiogenesis. Anat. Rec. (Hoboken) 292, 621\u2013632 (2009).","journal-title":"Anat. Rec. (Hoboken)"},{"key":"2811_CR399","doi-asserted-by":"publisher","first-page":"946786","DOI":"10.3389\/fimmu.2022.946786","volume":"13","author":"H Yoshitomi","year":"2022","unstructured":"Yoshitomi, H. Peripheral Helper T-Cell Responses in Human Diseases. Front. Immunol. 13, 946786 (2022).","journal-title":"Front. Immunol."},{"key":"2811_CR400","doi-asserted-by":"publisher","first-page":"101703","DOI":"10.1016\/j.smim.2022.101703","volume":"65","author":"WH Fridman","year":"2023","unstructured":"Fridman, W. H., Sib\u00e9ril, S., Pupier, G., Soussan, S. & Saut\u00e8s-Fridman, C. Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self? Semin. Immunol. 65, 101703 (2023).","journal-title":"Semin. Immunol."},{"key":"2811_CR401","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00262-025-04183-0","volume":"74","author":"C Tan","year":"2025","unstructured":"Tan, C. et al. Dynamic remodeling of tertiary lymphoid structures in response to cancer therapy: a recent review. Cancer Immunol. Immunother. 74, 313 (2025).","journal-title":"Cancer Immunol. Immunother."},{"key":"2811_CR402","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.4049\/jimmunol.1001836","volume":"185","author":"E Astorri","year":"2010","unstructured":"Astorri, E. et al. Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J. Immunol. 185, 3359\u20133368 (2010).","journal-title":"J. Immunol."},{"key":"2811_CR403","doi-asserted-by":"publisher","first-page":"e20232104","DOI":"10.1084\/jem.20232104","volume":"221","author":"M Ruggiu","year":"2024","unstructured":"Ruggiu, M. et al. Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T-cell responses in tumor-draining lymph nodes. J. Exp. Med. 221, e20232104 (2024).","journal-title":"J. Exp. Med."},{"key":"2811_CR404","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.intimp.2018.02.016","volume":"57","author":"L Li","year":"2018","unstructured":"Li, L., Ma, Y., Xu, Y. & Maerkeya, K. TIM-3 expression identifies a distinctive PD-1+ follicular helper T-cell subset, with reduced interleukin 21 production and B-cell help function in ovarian cancer patients. Int. Immunopharmacol. 57, 139\u2013146 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"2811_CR405","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","volume":"56","author":"F Wh","year":"2023","unstructured":"Wh, F. et al. Tertiary lymphoid structures and B cells: An intratumoral immunity cycle. Immunity 56, 2254\u20132269 (2023).","journal-title":"Immunity"},{"key":"2811_CR406","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1034\/j.1600-065X.2003.00058.x","volume":"194","author":"ICM MacLennan","year":"2003","unstructured":"MacLennan, I. C. M. et al. Extrafollicular antibody responses. Immunol. Rev. 194, 8\u201318 (2003).","journal-title":"Immunol. Rev."},{"key":"2811_CR407","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ccell.2023.03.015","volume":"41","author":"G Gaglia","year":"2023","unstructured":"Gaglia, G. et al. Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma. Cancer Cell 41, 871\u2013886.e10 (2023).","journal-title":"Cancer Cell"},{"key":"2811_CR408","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","volume":"42","author":"IP MacFawn","year":"2024","unstructured":"MacFawn, I. P. et al. The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell 42, 1864\u20131881.e5 (2024).","journal-title":"Cancer Cell"},{"key":"2811_CR409","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41556-024-01508-6","volume":"26","author":"X Hao","year":"2024","unstructured":"Hao, X. et al. Solid tumor-induced systemic immunosuppression involves dichotomous myeloid-B-cell interactions. Nat. Cell Biol. 26, 1971\u20131983 (2024).","journal-title":"Nat. Cell Biol."},{"key":"2811_CR410","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/01.moh.0000219664.26528.da","volume":"13","author":"HG Kopp","year":"2006","unstructured":"Kopp, H. G., Ramos, C. A. & Rafii, S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr. Opin. Hematol. 13, 175\u2013181 (2006).","journal-title":"Curr. Opin. Hematol."},{"key":"2811_CR411","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10456-015-9470-9","volume":"18","author":"E Fagiani","year":"2015","unstructured":"Fagiani, E. et al. An immature B-cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models. Angiogenesis 18, 327\u2013345 (2015).","journal-title":"Angiogenesis"},{"key":"2811_CR412","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/ATVBAHA.117.310626","volume":"38","author":"X Li","year":"2018","unstructured":"Li, X. et al. IL-35 (interleukin-35) suppresses endothelial cell activation by inhibiting mitochondrial reactive oxygen species-mediated site-specific acetylation of H3K14 (Histone 3 Lysine 14). Arterioscler. Thromb. Vasc. Biol. 38, 599\u2013609 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2811_CR413","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3389\/fimmu.2018.01941","volume":"9","author":"L Petersone","year":"2018","unstructured":"Petersone, L. et al. T-Cell\/B-cell collaboration and autoimmunity: An intimate relationship. Front. Immunol. 9, 1941 (2018).","journal-title":"Front. Immunol."},{"key":"2811_CR414","doi-asserted-by":"publisher","first-page":"954936","DOI":"10.3389\/fimmu.2022.954936","volume":"13","author":"I Rastogi","year":"2022","unstructured":"Rastogi, I. et al. Role of B cells as antigen presenting cells. Front. Immunol. 13, 954936 (2022).","journal-title":"Front. Immunol."},{"key":"2811_CR415","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev.iy.11.040193.001555","volume":"11","author":"DC Parker","year":"1993","unstructured":"Parker, D. C. T-cell-dependent B-cell activation. Annu. Rev. Immunol. 11, 331\u2013360 (1993).","journal-title":"Annu. Rev. Immunol."},{"key":"2811_CR416","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","volume":"29","author":"J Lv","year":"2023","unstructured":"Lv, J. et al. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment. Nat. Med. 29, 1424\u20131436 (2023).","journal-title":"Nat. Med."},{"key":"2811_CR417","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/jleuko\/qiad138","volume":"116","author":"L Hou","year":"2024","unstructured":"Hou, L. et al. Single-cell transcriptomics reveals tumor-infiltrating B-cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer. J. Leukoc. Biol. 116, 555\u2013564 (2024).","journal-title":"J. Leukoc. Biol."},{"key":"2811_CR418","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1007\/s00262-023-03505-4","volume":"72","author":"K Uehara","year":"2023","unstructured":"Uehara, K. et al. Preferential B-cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions. Cancer Immunol. Immunother. 72, 3543\u20133558 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"2811_CR419","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.annonc.2023.12.011","volume":"35","author":"N Gavrielatou","year":"2024","unstructured":"Gavrielatou, N. et al. B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma. Ann. Oncol. 35, 340\u2013350 (2024).","journal-title":"Ann. Oncol."},{"key":"2811_CR420","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03792-y","volume":"20","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing. J. Transl. Med. 20, 563 (2022).","journal-title":"J. Transl. Med."},{"key":"2811_CR421","doi-asserted-by":"publisher","first-page":"992343","DOI":"10.3389\/fgene.2022.992343","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Front. Genet. 13, 992343 (2022).","journal-title":"Front. Genet."},{"key":"2811_CR422","doi-asserted-by":"publisher","first-page":"892618","DOI":"10.3389\/fimmu.2022.892618","volume":"13","author":"S Pan","year":"2022","unstructured":"Pan, S. et al. Correlation of HBV DNA and Hepatitis B surface antigen levels with tumor response, liver function and immunological indicators in liver cancer patients with HBV infection undergoing PD-1 inhibition combinational therapy. Front. Immunol. 13, 892618 (2022).","journal-title":"Front. Immunol."},{"key":"2811_CR423","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01218-y","volume":"15","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence. Genome Med 15, 72 (2023).","journal-title":"Genome Med"},{"key":"2811_CR424","doi-asserted-by":"publisher","first-page":"e005802","DOI":"10.1136\/jitc-2022-005802","volume":"10","author":"RA Miller","year":"2022","unstructured":"Miller, R. A. et al. Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer. J. Immunother. Cancer 10, e005802 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR425","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.molimm.2019.02.009","volume":"109","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. PD-1-expressing B cells suppress CD4+ and CD8+ T cells via PD-1\/PD-L1-dependent pathway. Mol. Immunol. 109, 20\u201326 (2019).","journal-title":"Mol. Immunol."},{"key":"2811_CR426","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cytogfr.2023.11.002","volume":"75","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y., Richmond, A. & Yan, C. Harnessing the potential of CD40 agonism in cancer therapy. Cytokine Growth Factor Rev. 75, 40\u201356 (2024).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2811_CR427","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1158\/1078-0432.CCR-14-2355","volume":"21","author":"P Johnson","year":"2015","unstructured":"Johnson, P. et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin. Cancer Res. 21, 1321\u20131328 (2015).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR428","doi-asserted-by":"publisher","first-page":"1295218","DOI":"10.3389\/fimmu.2023.1295218","volume":"14","author":"D Hou","year":"2023","unstructured":"Hou, D. et al. Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma. Front. Immunol. 14, 1295218 (2023).","journal-title":"Front. Immunol."},{"key":"2811_CR429","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200913","volume":"218","author":"C Lee-Chang","year":"2021","unstructured":"Lee-Chang, C. et al. Activation of 4-1BBL+ B cells with CD40 agonism and IFN\u03b3 elicits potent immunity against glioblastoma. J. Exp. Med. 218, e20200913 (2021).","journal-title":"J. Exp. Med."},{"key":"2811_CR430","doi-asserted-by":"publisher","first-page":"e003078","DOI":"10.1136\/jitc-2021-003078","volume":"10","author":"AS Smith","year":"2022","unstructured":"Smith, A. S. et al. B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity. J. Immunother. Cancer 10, e003078 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR431","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.chembiol.2021.10.006","volume":"29","author":"L Sun","year":"2022","unstructured":"Sun, L. et al. Rapamycin targets STAT3 and impacts c-Myc to suppress tumor growth. Cell Chem. Biol. 29, 373\u2013385.e6 (2022).","journal-title":"Cell Chem. Biol."},{"key":"2811_CR432","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/neuonc\/noae167","volume":"27","author":"S Shen","year":"2025","unstructured":"Shen, S. et al. Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity. Neuro Oncol. 27, 140\u2013154 (2025).","journal-title":"Neuro Oncol."},{"key":"2811_CR433","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1054-1","volume":"568","author":"M Hamieh","year":"2019","unstructured":"Hamieh, M. et al. CAR T-cell trogocytosis and cooperative killing regulate tumor antigen escape. Nature 568, 112\u2013116 (2019).","journal-title":"Nature"},{"key":"2811_CR434","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10127-x","volume":"10","author":"M Thura","year":"2019","unstructured":"Thura, M. et al. PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nat. Commun. 10, 2484 (2019).","journal-title":"Nat. Commun."},{"key":"2811_CR435","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","volume":"175","author":"P Andr\u00e9","year":"2018","unstructured":"Andr\u00e9, P. et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell 175, 1731\u20131743.e13 (2018).","journal-title":"Cell"},{"key":"2811_CR436","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41421-023-00568-6","volume":"9","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. PPAR\u03b4 inhibition blocks the induction and function of tumor-induced IL-10+ regulatory B cells and enhances cancer immunotherapy. Cell Discov. 9, 54 (2023).","journal-title":"Cell Discov."},{"key":"2811_CR437","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1158\/1078-0432.CCR-19-2929","volume":"26","author":"M Meylan","year":"2020","unstructured":"Meylan, M. et al. Early hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive molecules. Clin. Cancer Res. 26, 4381\u20134389 (2020).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR438","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","volume":"41","author":"M Ramachandran","year":"2023","unstructured":"Ramachandran, M. et al. Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma. Cancer cell 41, 1134\u20131151.e10 (2023).","journal-title":"Cancer cell"},{"key":"2811_CR439","doi-asserted-by":"publisher","first-page":"e173712","DOI":"10.1172\/jci.insight.173712","volume":"9","author":"PZ Han","year":"2024","unstructured":"Han, P. Z. et al. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer. JCI insight 9, e173712 (2024).","journal-title":"JCI insight"},{"key":"2811_CR440","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","volume":"43","author":"Z Tang","year":"2025","unstructured":"Tang, Z. et al. Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures. Cancer Cell 43, 1025\u20131044.e14 (2025).","journal-title":"Cancer Cell"},{"key":"2811_CR441","doi-asserted-by":"publisher","first-page":"e005345","DOI":"10.1136\/jitc-2022-005345","volume":"10","author":"E K\u00fc\u00e7\u00fckk\u00f6se","year":"2022","unstructured":"K\u00fc\u00e7\u00fckk\u00f6se, E. et al. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice. J. Immunother. Cancer 10, e005345 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR442","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/0008-5472.CAN-24-2274","volume":"85","author":"T Ninomiya","year":"2025","unstructured":"Ninomiya, T. et al. Myeloid cells induce infiltration and activation of B cells and CD4+ T follicular helper cells to sensitize brain metastases to combination immunotherapy. Cancer Res. 85, 1082\u20131096 (2025).","journal-title":"Cancer Res."},{"key":"2811_CR443","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-023-05771-9","volume":"616","author":"WN Kevin","year":"2023","unstructured":"Kevin, W. N. et al. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature 616, 563\u2013573 (2023).","journal-title":"Nature"},{"key":"2811_CR444","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13045-022-01377-2","volume":"15","author":"M Spalato-Ceruso","year":"2022","unstructured":"Spalato-Ceruso, M. et al. Pembrolizumab combined with low-dose cyclophosphamide and intratumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study. J. Hematol. Oncol. 15, 157 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"2811_CR445","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki, M. et al. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature 638, 1076\u20131084 (2025).","journal-title":"Nature"},{"key":"2811_CR446","doi-asserted-by":"publisher","first-page":"e1583547","DOI":"10.1080\/2162402X.2019.1583547","volume":"8","author":"G Morcrette","year":"2019","unstructured":"Morcrette, G. et al. APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures. Oncoimmunology 8, e1583547 (2019).","journal-title":"Oncoimmunology"},{"key":"2811_CR447","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1097\/JS9.0000000000000741","volume":"109","author":"Y Wu","year":"2023","unstructured":"Wu, Y. et al. Association of systemic inflammatory markers and tertiary lymphoid structure with pathological complete response in gastric cancer patients receiving preoperative treatment: A retrospective cohort study. Int. J. Surg. 109, 4151\u20134161 (2023).","journal-title":"Int. J. Surg."},{"key":"2811_CR448","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1021\/acs.accounts.2c00360","volume":"55","author":"WH Li","year":"2022","unstructured":"Li, W. H., Su, J. Y. & Li, Y. M. Rational design of T-cell- and B-cell-based therapeutic cancer vaccines. Acc. Chem. Res. 55, 2660\u20132671 (2022).","journal-title":"Acc. Chem. Res."},{"key":"2811_CR449","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13046-022-02307-3","volume":"41","author":"X Bai","year":"2022","unstructured":"Bai, X. et al. Adaptive antitumor immune response stimulated by bionanoparticle based vaccine and checkpoint blockade. J. Exp. Clin. Cancer Res. 41, 132 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2811_CR450","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1021\/acsnano.3c13038","volume":"18","author":"C Li","year":"2024","unstructured":"Li, C. et al. Antigen-clustered nanovaccine achieves long-term tumor remission by promoting B\/CD 4 T-cell crosstalk. ACS Nano 18, 9584\u20139604 (2024).","journal-title":"ACS Nano"},{"key":"2811_CR451","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1158\/1078-0432.CCR-18-3997","volume":"25","author":"T Bekaii-Saab","year":"2019","unstructured":"Bekaii-Saab, T. et al. Phase I immunotherapy trial with two chimeric HER-2 B-cell peptide vaccines emulsified in montanide ISA 720VG and Nor-MDP adjuvant in patients with advanced solid tumors. Clin. Cancer Res. 25, 3495\u20133507 (2019).","journal-title":"Clin. Cancer Res."},{"key":"2811_CR452","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4143\/crt.2022.1328","volume":"56","author":"M Jung","year":"2024","unstructured":"Jung, M. et al. First-in-human phase 1 study of a B-cell- and monocyte-based immunotherapeutic vaccine against HER2-positive advanced gastric cancer. Cancer Res. Treat. 56, 208\u2013218 (2024).","journal-title":"Cancer Res. Treat."},{"key":"2811_CR453","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1007\/s00262-021-02914-7","volume":"70","author":"KL Oxley","year":"2021","unstructured":"Oxley, K. L., Hanson, B. M., Zani, A. N. & Bishop, G. A. Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine. Cancer Immunol. Immunother. 70, 3093\u20133103 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"2811_CR454","doi-asserted-by":"publisher","first-page":"e177384","DOI":"10.1172\/JCI177384","volume":"134","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. B-cell-based therapy produces antibodies that inhibit glioblastoma growth. J. Clin. Invest. 134, e177384 (2024).","journal-title":"J. Clin. Invest."},{"key":"2811_CR455","doi-asserted-by":"publisher","first-page":"221ra13","DOI":"10.1126\/scitranslmed.3007323","volume":"6","author":"L Maldonado","year":"2014","unstructured":"Maldonado, L. et al. Intramuscular therapeutic vaccination targeting HPV16 induces T-cell responses that localize in mucosal lesions. Sci. Transl. Med. 6, 221ra13 (2014).","journal-title":"Sci. Transl. Med."},{"key":"2811_CR456","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13046-024-03080-1","volume":"43","author":"C Curcio","year":"2024","unstructured":"Curcio, C. et al. PI3K\u03b3 inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer. J. Exp. Clin. Cancer Res. 43, 157 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2811_CR457","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10495-023-01868-8","volume":"28","author":"Y Shi","year":"2023","unstructured":"Shi, Y. et al. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Apoptosis 28, 1423\u20131435 (2023).","journal-title":"Apoptosis"},{"key":"2811_CR458","doi-asserted-by":"publisher","first-page":"e000544","DOI":"10.1136\/jitc-2020-000544","volume":"8","author":"P Ke","year":"2020","unstructured":"Ke, P. et al. Incomplete Freund\u2019s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment. J. Immunother. Cancer 8, e000544 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR459","doi-asserted-by":"publisher","first-page":"991433","DOI":"10.3389\/fimmu.2022.991433","volume":"13","author":"J Taylor","year":"2023","unstructured":"Taylor, J., Gandhi, A., Gray, E. & Zaenker, P. Checkpoint inhibitor immune-related adverse events: A focused review on autoantibodies and B cells as biomarkers, advancements and future possibilities. Front. Immunol. 13, 991433 (2023).","journal-title":"Front. Immunol."},{"key":"2811_CR460","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30863-x","volume":"13","author":"AJ Patel","year":"2022","unstructured":"Patel, A. J. et al. Regulatory B-cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade. Nat. Commun. 13, 3148 (2022).","journal-title":"Nat. Commun."},{"key":"2811_CR461","doi-asserted-by":"publisher","first-page":"e2205378119","DOI":"10.1073\/pnas.2205378119","volume":"119","author":"H Tsukamoto","year":"2022","unstructured":"Tsukamoto, H. et al. Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events. Proc. Natl. Acad. Sci. USA 119, e2205378119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2811_CR462","doi-asserted-by":"publisher","first-page":"e003585","DOI":"10.1136\/jitc-2021-003585","volume":"9","author":"SA Gonugunta","year":"2021","unstructured":"Gonugunta, S. A. et al. Humoral and cellular correlates of a novel immune-related adverse event and its treatment. J. Immunother. Cancer 9, e003585 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2811_CR463","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s43018-023-00572-5","volume":"4","author":"C Sung","year":"2023","unstructured":"Sung, C. et al. Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer. Nat. Cancer 4, 844\u2013859 (2023).","journal-title":"Nat. Cancer"},{"key":"2811_CR464","doi-asserted-by":"publisher","first-page":"RP87281","DOI":"10.7554\/eLife.87281","volume":"12","author":"MM Muthana","year":"2023","unstructured":"Muthana, M. M. et al. CTLA-4 antibody\u2012drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T-cell impairment. eLife 12, RP87281 (2023).","journal-title":"eLife"},{"key":"2811_CR465","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/neuonc\/noad198","volume":"26","author":"L M\u00fcller-Jensen","year":"2024","unstructured":"M\u00fcller-Jensen, L. et al. Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity. Neuro Oncol. 26, 279\u2013294 (2024).","journal-title":"Neuro Oncol."},{"key":"2811_CR466","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41591-022-02095-5","volume":"28","author":"CA Taylor","year":"2022","unstructured":"Taylor, C. A. et al. IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nat. Med. 28, 2592\u20132600 (2022).","journal-title":"Nat. Med."},{"key":"2811_CR467","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jmgm.2017.06.004","volume":"75","author":"M Mahdavi","year":"2017","unstructured":"Mahdavi, M., Moreau, V. & Kheirollahi, M. Identification of B and T-cell epitope based peptide vaccine from IGF-1 receptor in breast cancer. J. Mol. Graph. Model. 75, 316\u2013321 (2017).","journal-title":"J. Mol. Graph. Model."},{"key":"2811_CR468","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/d41586-024-00840-z","volume":"627","author":"L Drew","year":"2024","unstructured":"Drew, L. Cancer-vaccine trials give reasons for optimism. Nature 627, S33 (2024).","journal-title":"Nature"},{"key":"2811_CR469","first-page":"1973","volume":"6","author":"M Yang","year":"2021","unstructured":"Yang, M., Li, J., Gu, P. & Fan, X. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioact. Mater. 6, 1973\u20131987 (2021).","journal-title":"Bioact. Mater."},{"key":"2811_CR470","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202411361","volume":"37","author":"W Yan","year":"2025","unstructured":"Yan, W. et al. Personalized multi-epitope nanovaccine unlocks B-cell-mediated multiple pathways of antitumor immunity. Adv. Mater. 37, e2411361 (2025).","journal-title":"Adv. Mater."},{"key":"2811_CR471","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee, D. W. et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol. Blood Marrow Transplant. 25, 625\u2013638 (2019).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"2811_CR472","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.ymthe.2025.03.005","volume":"33","author":"KK Patel","year":"2025","unstructured":"Patel, K. K., Tariveranmoshabad, M., Kadu, S., Shobaki, N. & June, C. From concept to cure: The evolution of CAR-T-cell therapy. Mol. Ther. 33, 2123\u20132140 (2025).","journal-title":"Mol. Ther."},{"key":"2811_CR473","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41591-024-03360-5","volume":"31","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: A randomized phase 2 trial. Nat. Med. 31, 449\u2013456 (2025).","journal-title":"Nat. Med."},{"key":"2811_CR474","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi, M. et al. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol. Cancer 21, 28 (2022).","journal-title":"Mol. Cancer"},{"key":"2811_CR475","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A. J. & Hellmann, M. D. Acquired resistance to immune checkpoint inhibitors. Cancer Cell 37, 443\u2013455 (2020).","journal-title":"Cancer Cell"},{"key":"2811_CR476","doi-asserted-by":"publisher","first-page":"1268070","DOI":"10.3389\/fimmu.2023.1268070","volume":"14","author":"W Tian","year":"2023","unstructured":"Tian, W. et al. Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States. Front. Immunol. 14, 1268070 (2023).","journal-title":"Front. Immunol."},{"key":"2811_CR477","doi-asserted-by":"publisher","first-page":"eabf1152","DOI":"10.1126\/sciimmunol.abf1152","volume":"6","author":"M Silva","year":"2021","unstructured":"Silva, M. et al. A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity. Sci. Immunol. 6, eabf1152 (2021).","journal-title":"Sci. Immunol."},{"key":"2811_CR478","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.apsb.2020.12.018","volume":"11","author":"Q Xiao","year":"2021","unstructured":"Xiao, Q. et al. Biological drug and drug delivery-mediated immunotherapy. Acta Pharm. Sin. B 11, 941\u2013960 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"2811_CR479","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s00262-021-02895-7","volume":"70","author":"J Wenthe","year":"2021","unstructured":"Wenthe, J. et al. Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40\/4-1BB using oncolytic viral gene therapy. Cancer Immunol. Immunother. 70, 2851\u20132865 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"2811_CR480","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11523-017-0489-2","volume":"12","author":"JJ Mata-Molanes","year":"2017","unstructured":"Mata-Molanes, J. J., Sureda Gonz\u00e1lez, M., Valenzuela Jim\u00e9nez, B., Mart\u00ednez Navarro, E. M. & Brugarolas Masllorens, A. Cancer Immunotherapy with Cytokine-Induced Killer Cells. Target. Oncol. 12, 289\u2013299 (2017).","journal-title":"Target. Oncol."},{"key":"2811_CR481","doi-asserted-by":"publisher","first-page":"1393451","DOI":"10.3389\/fimmu.2024.1393451","volume":"15","author":"MY Chen","year":"2024","unstructured":"Chen, M. Y., Zhang, F., Goedegebuure, S. P. & Gillanders, W. E. Dendritic cell subsets and implications for cancer immunotherapy. Front. Immunol. 15, 1393451 (2024).","journal-title":"Front. Immunol."},{"key":"2811_CR482","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.ccell.2025.07.001","volume":"43","author":"AC Cole","year":"2025","unstructured":"Cole, A. C. et al. Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity. Cancer Cell 43, 1697\u20131713.e8 (2025).","journal-title":"Cancer Cell"},{"key":"2811_CR483","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55430-4","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang, L. et al. Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy. Nat. Commun. 16, 44 (2025).","journal-title":"Nat. Commun."},{"key":"2811_CR484","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","volume":"8","author":"N Xie","year":"2023","unstructured":"Xie, N. et al. Neoantigens: promising targets for cancer therapy. Signal Transduct. Target Ther. 8, 9 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2811_CR485","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41392-024-02096-5","volume":"10","author":"P Wang","year":"2025","unstructured":"Wang, P. et al. Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells. Signal Transduct. Target Ther. 10, 20 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"2811_CR486","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00262-025-04089-x","volume":"74","author":"X Cui","year":"2025","unstructured":"Cui, X. et al. Characteristics and outcomes of primary and secondary resistance to immune checkpoint inhibitors in hepatocellular carcinoma. Cancer Immunol. Immunother. 74, 239 (2025).","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02811-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02811-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02811-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:02:34Z","timestamp":1788822154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02811-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":486,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2811"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02811-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"371"}}